[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 255
1. Mertens F, Fletcher CD, Antonescu CR, Coindre JM, Colecchia M, Domanski HA, Downs-Kelly E, Fisher C, Goldblum JR, Guillou L, Reid R, Rosai J, Sciot R, Mandahl N, Panagopoulos I: Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest; 2005 Mar;85(3):408-15
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene.
  • Low-grade fibromyxoid sarcoma (LGFMS) is an indolent, late-metastasizing malignant soft-tissue tumor that is often mistaken for either more benign or more malignant tumor types.
  • [MeSH-major] Biomarkers, Tumor / genetics. Chromosomes, Human, Pair 16 / genetics. Chromosomes, Human, Pair 7 / genetics. Fibrosarcoma / genetics. Nerve Tissue Proteins / genetics. RNA-Binding Protein FUS / genetics. Soft Tissue Neoplasms / genetics. Transcription Factors / genetics. Translocation, Genetic
  • [MeSH-minor] Adolescent. Adult. Aged. Amino Acid Sequence. Base Sequence. Child. Cyclic AMP Response Element-Binding Protein. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Molecular Sequence Data. Recombinant Fusion Proteins / genetics. Reverse Transcriptase Polymerase Chain Reaction

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15640831.001).
  • [ISSN] 0023-6837
  • [Journal-full-title] Laboratory investigation; a journal of technical methods and pathology
  • [ISO-abbreviation] Lab. Invest.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CREB3L1 protein, human; 0 / Cyclic AMP Response Element-Binding Protein; 0 / Nerve Tissue Proteins; 0 / RNA-Binding Protein FUS; 0 / Recombinant Fusion Proteins; 0 / Transcription Factors
  •  go-up   go-down


2. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, Ricci F, Weber K, Furlong MA, Fisher C, Montgomery E: Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol; 2005 May;29(5):653-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Since low-grade sarcomas in general lack beta-catenin and since reactive proliferations would not be expected to have it, we predicted that nuclear beta-catenin expression would be detected in deep fibromatoses but absent in other entities in the differential diagnosis.
  • Formalin-fixed, paraffin-embedded sections from 21 lesions from 20 patients with deep fibromatoses were stained with monoclonal beta-catenin antibody (Transduction Laboratories) and compared with low-grade fibromyxoid sarcoma (n=12), leiomyosarcoma (n=10), various other fibrosarcoma variants (n=13, including 3 myofibrosarcomas, 3 sclerosing epithelioid fibrosarcomas, 5 low-grade fibrosarcomas, 1 classic fibrosarcoma arising in dermatofibrosarcoma protuberans, 1 inflammatory myxohyaline tumor/myxoinflammatory fibroblastic sarcoma), myofibroma/myofibromatosis (n=12), nodular fasciitis (n=11), and scars (n=9).
  • [MeSH-major] Cell Nucleus / pathology. Cytoskeletal Proteins / metabolism. Fibroblasts / pathology. Fibromatosis, Abdominal / pathology. Sarcoma / pathology. Trans-Activators / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / metabolism. Child. Cicatrix / metabolism. Cicatrix / pathology. Cytoplasm / metabolism. Cytoplasm / pathology. Diagnosis, Differential. Fasciitis / metabolism. Fasciitis / pathology. Female. Humans. Male. Middle Aged. beta Catenin

  • Genetic Alliance. consumer health - Fibromatosis.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15832090.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CTNNB1 protein, human; 0 / Cytoskeletal Proteins; 0 / Trans-Activators; 0 / beta Catenin
  •  go-up   go-down


3. Li X, Chen X, Shi ZH, Chen Y, Ye J, Qiao L, Qiu JH: Primary myxofibrosarcoma of the parotid: case report. BMC Cancer; 2010;10:246
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Fibrosarcoma / pathology. Myxosarcoma / pathology. Parotid Neoplasms / pathology
  • [MeSH-minor] Adult. Female. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Laryngol Otol. 2002 Jun;116(6):464-6 [12385363.001]
  • [Cites] Hum Pathol. 2004 May;35(5):612-21 [15138937.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1975 May;39(5):713-7 [1056575.001]
  • [Cites] Acta Pathol Microbiol Scand A. 1977 Mar;85A(2):127-40 [15396.001]
  • [Cites] Cancer. 1977 Apr;39(4):1672-85 [192434.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1979 Feb 9;381(2):121-39 [154761.001]
  • [Cites] Acta Cytol. 1980 Mar-Apr;24(2):137-44 [6154396.001]
  • [Cites] Am J Surg Pathol. 1981 Dec;5(8):753-60 [6278974.001]
  • [Cites] Del Med J. 1982 Mar;54(3):147-52 [7067862.001]
  • [Cites] Acta Pathol Microbiol Immunol Scand Suppl. 1983;282:1-40 [6444190.001]
  • [Cites] Am J Surg Pathol. 1996 Apr;20(4):391-405 [8604805.001]
  • [Cites] Hum Pathol. 1998 Dec;29(12):1372-81 [9865822.001]
  • [Cites] Ultrastruct Pathol. 2004 Sep-Dec;28(5-6):321-32 [15764580.001]
  • [Cites] Auris Nasus Larynx. 2006 Mar;33(1):93-6 [16183234.001]
  • [Cites] J Laryngol Otol. 2006 Oct;120(10):872-4 [17038234.001]
  • [Cites] Auris Nasus Larynx. 2008 Dec;35(4):583-6 [18262374.001]
  • [Cites] Am J Otolaryngol. 2009 Jul-Aug;30(4):264-8 [19563939.001]
  • [Cites] Ann Diagn Pathol. 2009 Oct;13(5):334-8 [19751910.001]
  • [Cites] Virchows Arch. 2010 Feb;456(2):201-17 [20217954.001]
  • [Cites] Mod Pathol. 2004 Feb;17(2):235-40 [14685255.001]
  • [Cites] Pathol Int. 2002 Sep;52(9):595-606 [12406189.001]
  • (PMID = 20513245.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2887780
  •  go-up   go-down


Advertisement
4. Rodriguez FJ, Scheithauer BW, Jenkins R, Burger PC, Rudzinskiy P, Vlodavsky E, Schooley A, Landolfi J: Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study. Am J Surg Pathol; 2007 Mar;31(3):351-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The sarcomatous component developed in recurrent/progressive tumors in 6 cases but was a focal finding at first tumor resection in 1 and included fibrosarcoma (n=5), leiomyosarcoma (n=1), or pleomorphic myogenic sarcoma (n=1).
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / analysis. Brain / surgery. Chromosome Deletion. Chromosomes, Human, Pair 1 / genetics. Chromosomes, Human, Pair 19 / genetics. Combined Modality Therapy. Fatal Outcome. Female. Humans. Immunohistochemistry. In Situ Hybridization, Fluorescence. Male. Middle Aged. Neoplasm Recurrence, Local. Neoplasm Staging

  • Genetic Alliance. consumer health - Gliosarcoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17325476.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


5. Virgintino D, Errede M, Girolamo F, Capobianco C, Robertson D, Vimercati A, Serio G, Di Benedetto A, Yonekawa Y, Frei K, Roncali L: Fetal blood-brain barrier P-glycoprotein contributes to brain protection during human development. J Neuropathol Exp Neurol; 2008 Jan;67(1):50-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To establish an immunohistochemical procedure for P-gp detection, different anti-P-gp monoclonal antibodies were first tested on a fibrosarcoma cell line and colonic carcinoma tissue.
  • The protocol was then tested on adult human brains as a BBB-P-gp tissue-specific control and for double labeling with anti-P-gp and the astroglia marker glial fibrillary acidic protein (GFAP).
  • [MeSH-minor] Adult. Age Factors. Carcinoma / metabolism. Caveolins / metabolism. Cell Line, Tumor. Colonic Neoplasms / metabolism. Female. Fetus. Fibrosarcoma / metabolism. Glial Fibrillary Acidic Protein / metabolism. Humans. Male. Middle Aged. Vimentin / metabolism


6. Koh SH, Choe HS, Lee IJ, Park HR, Bae SH: Low-grade fibromyxoid sarcoma: ultrasound and magnetic resonance findings in two cases. Skeletal Radiol; 2005 Sep;34(9):550-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low-grade fibromyxoid sarcoma: ultrasound and magnetic resonance findings in two cases.
  • Low-grade fibromyxoid sarcoma is a rare, slow-growing, yet metastasizing neoplasm characterized by histopathological fibrous/myxoid zonal alternations, which occasionally display an intralesional multinodular appearance.
  • We report on the radiological features of two cases of low-grade fibromyxoid sarcoma.
  • [MeSH-major] Fibroma / diagnosis. Fibrosarcoma / diagnosis. Soft Tissue Neoplasms / diagnosis. Thigh. Thoracic Wall
  • [MeSH-minor] Adult. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Radiography. Ultrasonography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiology. 1992 May;183(2):341-6 [1561333.001]
  • [Cites] Ann Diagn Pathol. 2000 Aug;4(4):207-17 [10982298.001]
  • [Cites] Comput Med Imaging Graph. 1996 May-Jun;20(3):163-9 [8930469.001]
  • [Cites] BMC Surg. 2003 Sep 24;3:7 [14507419.001]
  • [Cites] Am J Surg Pathol. 1993 Jun;17(6):595-600 [8333558.001]
  • [Cites] Cancer. 1999 Apr 25;87(2):75-82 [10227597.001]
  • [Cites] Am J Clin Pathol. 1987 Nov;88(5):615-9 [3673943.001]
  • [Cites] Histopathology. 1997 Mar;30(3):274-6 [9088959.001]
  • [Cites] Am J Surg Pathol. 2000 Oct;24(10):1353-60 [11023096.001]
  • (PMID = 15592668.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


7. Wong NL, DI F: [Fine needle aspiration cytology of myxoid lesions of soft tissues: a study of 24 cases]. Zhonghua Bing Li Xue Za Zhi; 2007 Sep;36(9):619-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To summarize the diagnostic features of fine needle aspiration cytology (FNAC) of myxoid lesions in soft tissue, and to define the cytological criteria for differentiating benign lesions from sarcomas and between various myxoid lesions.
  • Myxoid liposarcoma, extraskeletal myxoid chondrosarcoma and myxofibrosarcoma were the most common myxoid sarcomas.
  • [MeSH-major] Biopsy, Fine-Needle / methods. Fibrosarcoma / pathology. Ganglion Cysts / pathology. Liposarcoma, Myxoid / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Bone Neoplasms / pathology. Bone Neoplasms / surgery. Chondrosarcoma / pathology. Chondrosarcoma / surgery. Diagnosis, Differential. Fasciitis / pathology. Fasciitis / surgery. Female. Humans. Male. Middle Aged. Myxoma / pathology. Myxoma / surgery. Prognosis. Sarcoma / pathology. Sarcoma / surgery. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18070452.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


8. Blizniukov OP, Smirnova EA: [Sclerosing epithelial fibrosarcoma: a clinico-morphological evaluation of 10 cases]. Vopr Onkol; 2009;55(5):586-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Sclerosing epithelial fibrosarcoma: a clinico-morphological evaluation of 10 cases].
  • Sclerosing epithelial fibrosarcoma is a malignant mesenchymal tumor (fibroblastic class).
  • Differentiated analysis of epithelioid fibrosarcoma may also be done by computed microscopy and immunomorphology using other tumor models consisting of light-cytoplasm epitheloid cells, mostly osteosarcoma, clear-cell renal carcinoma, melanoma, synovial sarcoma and clear-cell sarcoma of the tendon sheath and aponeurosis.
  • [MeSH-major] Biomarkers, Tumor / analysis. Epithelioid Cells / pathology. Fibrosarcoma / diagnosis
  • [MeSH-minor] Abdomen. Adult. Back. Female. Humans. Leg. Male. Middle Aged. Neoplasm Recurrence, Local / diagnosis. Sclerosis. Thorax

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20020654.001).
  • [ISSN] 0507-3758
  • [Journal-full-title] Voprosy onkologii
  • [ISO-abbreviation] Vopr Onkol
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


9. da Cunha IW, Kowalski LP, Soares FA: Dedifferentiated liposarcoma of the oral cavity with angiosarcomatous dedifferentiation. Virchows Arch; 2005 Apr;446(4):456-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Dedifferentiation in liposarcomas occurs in about 10% of the cases and, when it occurs, the dedifferentiated areas usually resemble high-grade fibrosarcoma or pleomorphic sarcoma.
  • [MeSH-minor] Adult. Cell Transformation, Neoplastic. Disease-Free Survival. Female. Humans. Radiotherapy, Adjuvant. Treatment Outcome

  • Genetic Alliance. consumer health - Liposarcoma.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Head Neck. 1992 Jan-Feb;14(1):1-7 [1624288.001]
  • [Cites] J Otolaryngol. 2002 Apr;31(2):125-8 [12019743.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Sep;94(3):333-7 [12324789.001]
  • [Cites] Int J Surg Pathol. 2002 Jan;10(1):75-9 [11927975.001]
  • [Cites] Am J Surg Pathol. 1998 Aug;22(8):945-55 [9706974.001]
  • [Cites] Semin Diagn Pathol. 2001 Nov;18(4):263-6 [11757866.001]
  • [Cites] Mod Pathol. 2002 Oct;15(10):1020-31 [12379747.001]
  • [Cites] Am J Surg Pathol. 1997 Mar;21(3):271-81 [9060596.001]
  • [Cites] Virchows Arch Pathol Anat Physiol Klin Med. 1962;335:367-88 [13890373.001]
  • [Cites] J Clin Periodontol. 2001 Feb;28(2):109-12 [11168734.001]
  • [Cites] Am J Surg Pathol. 1994 Nov;18(11):1150-7 [7943536.001]
  • [Cites] Ann Surg. 1944 Jan;119(1):86-107 [17858339.001]
  • [Cites] Cancer. 1960 Sep-Oct;13:932-50 [13696965.001]
  • [Cites] Ann Diagn Pathol. 2000 Aug;4(4):252-66 [10982304.001]
  • [Cites] J Oral Pathol Med. 1999 Feb;28(2):92-5 [9950257.001]
  • [Cites] Br J Cancer. 1970 Dec;24(4):696-704 [5503596.001]
  • [Cites] Semin Oncol. 1981 Jun;8(2):185-9 [7196088.001]
  • [Cites] Ann Diagn Pathol. 2002 Apr;6(2):83-93 [12004355.001]
  • [Cites] Acta Pathol Jpn. 1982 Nov;32(6):933-48 [6297235.001]
  • [Cites] Am J Surg Pathol. 1994 Dec;18(12):1213-23 [7977944.001]
  • [Cites] Cancer. 1995 Sep 15;76(6):1051-8 [8625207.001]
  • [Cites] Oral Oncol. 2002 Dec;38(8):757-62 [12570054.001]
  • [Cites] Pathol Int. 2000 Jul;50(7):558-61 [10886740.001]
  • (PMID = 15806379.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 25
  •  go-up   go-down


10. Kim SY, Kim MY, Hwang YJ, Han YH, Seo JW, Kim YH, Cha SJ, Hur G: Low-grade fibromyxoid sarcoma: CT, sonography, and MR findings in 3 cases. J Thorac Imaging; 2005 Nov;20(4):294-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low-grade fibromyxoid sarcoma: CT, sonography, and MR findings in 3 cases.
  • Low-grade fibromyxoid sarcoma (LGFMS) is a distinctive variant of fibrosarcoma characterized by deceptively bland histologic features and a paradoxically aggressive clinical course.
  • [MeSH-major] Fibrosarcoma / diagnosis. Pleural Neoplasms / diagnosis. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Axilla. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Male. Thoracic Wall. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16282909.001).
  • [ISSN] 0883-5993
  • [Journal-full-title] Journal of thoracic imaging
  • [ISO-abbreviation] J Thorac Imaging
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


11. Colombo N, Formelli F, Cantù MG, Parma G, Gasco M, Argusti A, Santinelli A, Montironi R, Cavadini E, Baglietto L, Guerrieri-Gonzaga A, Viale G, Decensi A: A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer. Cancer Epidemiol Biomarkers Prev; 2006 Oct;15(10):1914-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / blood. CA-125 Antigen / blood. CA-125 Antigen / drug effects. Carcinoid Tumor / blood. Carcinoid Tumor / drug therapy. Carcinoid Tumor / pathology. Carcinoid Tumor / surgery. Case-Control Studies. Cell Proliferation / drug effects. Chromatography, High Pressure Liquid. Dose-Response Relationship, Drug. Feasibility Studies. Female. Fibrosarcoma / blood. Fibrosarcoma / drug therapy. Fibrosarcoma / pathology. Fibrosarcoma / surgery. Humans. Ki-67 Antigen / blood. Ki-67 Antigen / drug effects. Linear Models. Middle Aged. Neoplasm Staging. Treatment Outcome. Vitamin A / blood

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • Hazardous Substances Data Bank. VITAMIN A .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17035399.001).
  • [ISSN] 1055-9965
  • [Journal-full-title] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • [ISO-abbreviation] Cancer Epidemiol. Biomarkers Prev.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Biomarkers, Tumor; 0 / CA-125 Antigen; 0 / Ki-67 Antigen; 11103-57-4 / Vitamin A; 187EJ7QEXL / Fenretinide
  •  go-up   go-down


12. Edelweiss M, Malpica A: Dermatofibrosarcoma protuberans of the vulva: a clinicopathologic and immunohistochemical study of 13 cases. Am J Surg Pathol; 2010 Mar;34(3):393-400
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Dermatofibrosarcoma protuberans (DFSP) is a low-grade sarcoma seldom seen in the vulva with only 29 cases reported.
  • Of interest, in 7 of our 13 cases, a variety of diagnoses, such as cellular dermatofibroma, cellular leiomyoma, neurofibroma, low-grade leiomyosarcoma, fibrosarcoma, low-grade malignant schwannoma, desmoplastic melanoma, cellular neurofibroma, and low-grade malignant peripheral nerve sheet tumor were initially considered.
  • [MeSH-minor] Adult. Aged. Chemotherapy, Adjuvant. Diagnosis, Differential. Female. Gynecologic Surgical Procedures. Humans. Middle Aged. Neoplasm Recurrence, Local. Predictive Value of Tests. Radiotherapy, Adjuvant. Reoperation. Time Factors. Treatment Outcome. Young Adult


13. Dayan D, Nasrallah V, Vered M: Clinico-pathologic correlations of myofibroblastic tumors of the oral cavity: 1. Nodular fasciitis. J Oral Pathol Med; 2005 Aug;34(7):426-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Histopathologically, NF should be differentiated from other spindle cell lesions, mainly myofibroma, neurofibroma, fibrosarcoma, solitary fibrous tumor, fibromatosis and fibrous histiocytoma.
  • [MeSH-minor] Adult. Age Factors. Female. Humans. Male. Middle Aged. Mouth Floor / pathology. Mouth Mucosa / pathology. Recurrence

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16011613.001).
  • [ISSN] 0904-2512
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Denmark
  • [Number-of-references] 46
  •  go-up   go-down


14. Rong BG, Chen WL, Ding YP, Xie G, Chen Y, Wang TD: [Surgical approaches to the skull base neoplasms]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Apr;40(4):291-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • For 50 patients with malignant tumor including 3 cases of well-differentiated squamous cell carcinoma, 17 cases of moderately differentiated squamous cell carcinoma, 11 cases of poorly differentiated squamous cell carcinoma, 1 case of undifferentiated carcinoma, 2 cases of chondrosarcoma, 5 cases of canceration of papilloma, 2 cases of adenocarcinoma, 1 case of esthesioneuroblastoma, 2 cases of malignant fibrohistiocytoma, 1 case of fibrosarcoma, 2 cases of malignant mixed tumour, 3 cases of sarcoma survival rates of 3 and 5 years were 59.2% (29/49), 38.5% (10/26) respectively.
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16008265.001).
  • [ISSN] 1673-0860
  • [Journal-full-title] Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
  • [ISO-abbreviation] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


15. Frank S, Cordier D, Tolnay M, Rosenblum MK: A 28-year-old man with headache, visual and aphasic speech disturbances. Brain Pathol; 2009 Jan;19(1):163-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Indeed, only 14 months later, the patient presented with a recurrent lesion, which contained the previous histology, but now also featured a distinct fibrosarcoma-like component replete with numerous osteoclast-type giant cells.
  • [MeSH-minor] Adult. Antigens, CD34 / analysis. Humans. Immunohistochemistry / methods. Magnetic Resonance Imaging. Male. Neoplasm Recurrence, Local

  • MedlinePlus Health Information. consumer health - Aphasia.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Headache.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19076784.001).
  • [ISSN] 1750-3639
  • [Journal-full-title] Brain pathology (Zurich, Switzerland)
  • [ISO-abbreviation] Brain Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Antigens, CD34
  •  go-up   go-down


16. Ahmed AA, Ostlie D, Fraser JD, Newell B, Cooley L: Dermatofibrosarcoma protuberans in the breast of a 2-year-old girl. Ann Diagn Pathol; 2010 Aug;14(4):279-83
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The histology of the excised mass revealed a moderately cellular spindle cell tumor with large hypercellular fibrosarcoma-like areas, few myxoid areas, and other areas with multinucleated giant cells.
  • Although DFSP has been described in the adult female breast, this is the first such case in the breast of a 2-year-old girl.

  • Genetic Alliance. consumer health - Dermatofibrosarcoma Protuberans.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20637435.001).
  • [ISSN] 1532-8198
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD34; EC 2.7.10.1 / Receptor, Platelet-Derived Growth Factor beta
  •  go-up   go-down


17. Nistor C, Davidescu M, Rus O, Marinescu B, Stefănescu I, Tudose A, Horvat T: Giant laterocervical fibrosarcom. J Med Life; 2009 Jul-Sep;2(3):262-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Soft tissue sarcomas are rare tumors representing 1% of all malignancies and less than 10% concerning head and neck tumors.
  • Histopathological examination revealed an intermediate-grade fibrosarcoma.
  • [MeSH-major] Fibrosarcoma / pathology. Fibrosarcoma / surgery. Head and Neck Neoplasms / pathology. Head and Neck Neoplasms / surgery. Soft Tissue Neoplasms / pathology. Soft Tissue Neoplasms / surgery
  • [MeSH-minor] Adult. Humans. Male. Skin Transplantation

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20112469.001).
  • [ISSN] 1844-122X
  • [Journal-full-title] Journal of medicine and life
  • [ISO-abbreviation] J Med Life
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


18. Fujita S, Hideshima K, Ikeda T: Nestin expression in odontoblasts and odontogenic ectomesenchymal tissue of odontogenic tumours. J Clin Pathol; 2006 Mar;59(3):240-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Odontoblasts and their processes, pulp cells near the positive odontoblasts, and flat cells adhering to the dentine showed immunoreaction with nestin in the odontomas and odontoma-like component in the ameloblastic fibro-odontomas.
  • [MeSH-minor] Adolescent. Adult. Ameloblastoma / chemistry. Female. Fibroma / chemistry. Fibrosarcoma / chemistry. Humans. Immunohistochemistry / methods. Male. Middle Aged. Myxoma / chemistry. Nestin. Odontoblasts / chemistry. Odontogenesis. Odontoma / chemistry. Sensitivity and Specificity

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Virchows Arch. 2000 Apr;436(4):324-9 [10834534.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1954 Oct;7(10):1091-1107 [13203953.001]
  • [Cites] J Oral Pathol Med. 2000 Nov;29(10):483-90 [11048964.001]
  • [Cites] J Oral Pathol Med. 2001 Apr;30(4):237-44 [11302244.001]
  • [Cites] Adv Dent Res. 2001 Aug;15:4-7 [12640730.001]
  • [Cites] Adv Dent Res. 2001 Aug;15:59-62 [12640742.001]
  • [Cites] Arch Oral Biol. 2003 Apr;48(4):273-83 [12663072.001]
  • [Cites] Arch Oral Biol. 2003 Oct;48(10):731-6 [12971951.001]
  • [Cites] Glia. 2004 Sep;47(4):299-313 [15293228.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1978 Sep;46(3):396-406 [151250.001]
  • [Cites] J Maxillofac Surg. 1986 Feb;14(1):46-52 [3456413.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1988;413(4):341-7 [2459840.001]
  • [Cites] Am J Med Genet Suppl. 1988;4:7-22 [3144987.001]
  • [Cites] Cell. 1990 Feb 23;60(4):585-95 [1689217.001]
  • [Cites] Lab Invest. 1992 Mar;66(3):303-13 [1538585.001]
  • [Cites] Pathol Res Pract. 1992 Feb;188(1-2):141-4 [1594483.001]
  • [Cites] Cancer Res. 1992 Oct 1;52(19):5334-41 [1382841.001]
  • [Cites] Cancer Res. 1994 Jan 15;54(2):354-6 [8275467.001]
  • [Cites] J Cell Sci. 1993 Dec;106 ( Pt 4):1291-300 [8126108.001]
  • [Cites] Dev Biol. 1994 Sep;165(1):216-28 [8088440.001]
  • [Cites] J Histochem Cytochem. 1995 Aug;43(8):843-7 [7542682.001]
  • [Cites] Int J Dev Biol. 1995 Feb;39(1):51-68 [7626422.001]
  • [Cites] J Cell Biol. 1995 Oct;131(2):453-64 [7593171.001]
  • [Cites] Int J Dev Biol. 1995 Dec;39(6):947-56 [8901197.001]
  • [Cites] Eur J Neurosci. 1997 Jan;9(1):65-75 [9042570.001]
  • [Cites] Differentiation. 1997 May;61(4):243-9 [9203347.001]
  • [Cites] Neurobiol Dis. 1995 Apr;2(2):79-85 [8980011.001]
  • [Cites] Pathol Res Pract. 1999;195(6):391-7 [10399179.001]
  • [Cites] Am J Pathol. 2000 Jul;157(1):287-95 [10880398.001]
  • (PMID = 16505272.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Intermediate Filament Proteins; 0 / NES protein, human; 0 / Nerve Tissue Proteins; 0 / Nestin
  • [Other-IDs] NLM/ PMC1860355
  •  go-up   go-down


19. Li ZJ, Sun P, Guo Y, Wang RZ: Primary pituitary fibrosarcoma presenting with multiple metastases: a case report and literature review. Neurol India; 2010 Mar-Apr;58(2):316-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary pituitary fibrosarcoma presenting with multiple metastases: a case report and literature review.
  • Even though many cases of pituitary fibrosarcoma (PF) have been reported, the etiologic classification of these tumors, however, remains undefined.
  • Moreover, owing to the paucity of available case studies, the clinical characteristics of primary pituitary fibrosarcoma (PPF) have not been fully described.
  • [MeSH-major] Fibrosarcoma / pathology. Neoplasm Recurrence, Local / secondary. Pituitary Neoplasms / pathology
  • [MeSH-minor] Adult. Female. Humans. Ki-67 Antigen / metabolism. Magnetic Resonance Imaging / methods. Tumor Suppressor Protein p53 / metabolism

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20508360.001).
  • [ISSN] 0028-3886
  • [Journal-full-title] Neurology India
  • [ISO-abbreviation] Neurol India
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] India
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / Tumor Suppressor Protein p53
  • [Number-of-references] 13
  •  go-up   go-down


20. El Mesbahi O, Arifi S, Benbrahim Z, El Ibrahimi A, Kettani F, Bennani A, Amarti A, Lamrani MY, Tizniti S, El Mrini A: A rare case of locally advanced fibrosarcoma of diaphysal humerus managed successfully with limb-sparing procedures after neoadjuvant chemotherapy. World J Surg Oncol; 2010;8:77
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A rare case of locally advanced fibrosarcoma of diaphysal humerus managed successfully with limb-sparing procedures after neoadjuvant chemotherapy.
  • Fibrosarcomas (FS) of bone are a rare malignancy accounting for less than 5% of all primary malignant bone neoplasms.
  • [MeSH-major] Bone Neoplasms / surgery. Fibrosarcoma / surgery. Humerus
  • [MeSH-minor] Adult. Chemotherapy, Adjuvant. Diaphyses. Female. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Neoadjuvant Therapy. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Orthop Relat Res. 2000 Apr;(373):88-103 [10810466.001]
  • [Cites] Cancer. 1975 Mar;35(3):837-47 [1053940.001]
  • [Cites] Cancer. 1995 Jan 1;75(1 Suppl):203-10 [8000997.001]
  • [Cites] Int J Clin Oncol. 2006 Jun;11(3):229-35 [16850130.001]
  • [Cites] Arch Phys Med Rehabil. 1999 Jun;80(6):615-8 [10378484.001]
  • [Cites] Eur J Cell Biol. 2004 Sep;83(9):483-91 [15540465.001]
  • [Cites] Clin Orthop Relat Res. 1999 May;(362):181-9 [10335297.001]
  • (PMID = 20819211.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2945346
  •  go-up   go-down


21. Katz P, Colbert R, Drolet B: Unilateral mosaic cutaneous vascular lesions, enchondroma, multiple soft tissue chondromas and congenital fibrosarcoma--a variant of Maffucci syndrome? Pediatr Dermatol; 2008 Mar-Apr;25(2):205-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unilateral mosaic cutaneous vascular lesions, enchondroma, multiple soft tissue chondromas and congenital fibrosarcoma--a variant of Maffucci syndrome?
  • Of interest, this patient also has a history of congenital fibrosarcoma with concomitant thrombocytopenia.
  • [MeSH-minor] Adult. Axilla. Biopsy. Dermis / blood supply. Diagnosis, Differential. Fibrosarcoma / congenital. Fibrosarcoma / diagnosis. Humans. Infant, Newborn. Male. Telangiectasis / congenital. Telangiectasis / diagnosis. Vascular Malformations / diagnosis


22. Khor TS, Sinniah R: Leiomyosarcoma of the bone: a case report of a rare tumour and problems involved in diagnosis. Pathology; 2010 Jan;42(1):87-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Actins / metabolism. Adult. Biomarkers, Tumor / metabolism. Diagnosis, Differential. Female. Femur / pathology. Femur / surgery. Fibrosarcoma / diagnosis. Humans. Knee Joint / pathology. Knee Joint / surgery. Leiomyoma / diagnosis. Magnetic Resonance Imaging. Muscle, Smooth / ultrastructure. Neoadjuvant Therapy. Osteosarcoma / diagnosis. Soft Tissue Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20025489.001).
  • [ISSN] 1465-3931
  • [Journal-full-title] Pathology
  • [ISO-abbreviation] Pathology
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Actins; 0 / Biomarkers, Tumor
  •  go-up   go-down


23. Kousar A, Hosein MM, Ahmed Z, Minhas K: Rapid sarcomatous transformation of an ameloblastic fibroma of the mandible: case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep;108(3):e80-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ameloblastic fibrosarcoma (AFS) is a rare malignant odontogenic tumour regarded as the malignant counterpart of ameloblastic fibroma.
  • Initially histopathologically diagnosed as a benign lesion, it rapidly recurred with apparent transformation into a high-grade sarcoma over a period of 6 months.
  • [MeSH-major] Cell Transformation, Neoplastic / pathology. Mandibular Neoplasms / pathology. Odontogenic Tumors / pathology. Sarcoma / pathology
  • [MeSH-minor] Brain Neoplasms / secondary. Fatal Outcome. Female. Follow-Up Studies. Humans. Lung Neoplasms / secondary. Masseter Muscle / pathology. Muscle Neoplasms / pathology. Neoplasm Invasiveness. Neoplasm Recurrence, Local / pathology. Radiography, Panoramic. Skull Neoplasms / pathology. Sphenoid Bone / pathology. Tomography, X-Ray Computed. Young Adult

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19716496.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 21
  •  go-up   go-down


24. Abbes K, Bahri Zouari I, Makni S, Chtourou I, Khabir A, Gouiaa N, Ayadi L, Mnif H, Sellami-Boudawara T: [A rare tumor of soft tissues of the foot]. Ann Pathol; 2007 Apr;27(2):157-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Fibrosarcoma / pathology. Foot Diseases / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Female. Humans

  • MedlinePlus Health Information. consumer health - Foot Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17909480.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


25. Velazquez EF, Melamed J, Barreto JE, Aguero F, Cubilla AL: Sarcomatoid carcinoma of the penis: a clinicopathologic study of 15 cases. Am J Surg Pathol; 2005 Sep;29(9):1152-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Microscopically, the lesions were predominantly composed of atypical spindle cells disposed in interlacing fascicles, resembling fibrosarcoma or leiomyosarcoma, sometimes admixed with pleomorphic giant cells mimicking malignant fibrous histiocytoma.
  • Differential diagnoses include sarcoma and melanoma.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Diagnosis, Differential. Humans. Immunohistochemistry. In Situ Hybridization. Male. Middle Aged

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16096403.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


26. Liu QY, Li HG, Chen JY, Liang BL: [Correlation of MRI features to histopathologic grade of soft tissue sarcoma]. Ai Zheng; 2008 Aug;27(8):856-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Correlation of MRI features to histopathologic grade of soft tissue sarcoma].
  • BACKGROUND & OBJECTIVE: Peripheral tumor growth pattern plays an important role in the local recurrence and metastases of soft tissue sarcoma.
  • This study was to determine the peripheral growth pattern of soft tissue sarcoma by magnetic resonance imaging (MRI), explore its correlation to histological grade, and assess biological features of soft tissue sarcoma before operation.
  • METHODS: MRI was performed in 59 patients with soft tissue sarcoma.
  • RESULTS: The histological grade of soft tissue sarcoma was closely related to the margin appearance (P<0.05): the margin was well defined in 60.0% grade I tumors, and poorly defined in 60.0% grade III tumors.
  • CONCLUSION: The peripheral tumor growth pattern is related with histological grade, and may reflect the biological behaviors of soft tissue sarcoma.
  • [MeSH-major] Magnetic Resonance Imaging. Sarcoma / diagnosis. Sarcoma / pathology. Soft Tissue Neoplasms / diagnosis. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Extremities. Female. Fibrosarcoma / diagnosis. Fibrosarcoma / pathology. Histiocytoma, Malignant Fibrous / diagnosis. Histiocytoma, Malignant Fibrous / pathology. Humans. Infant. Liposarcoma / diagnosis. Liposarcoma / pathology. Male. Middle Aged. Neoplasm Staging. Young Adult


27. Petrov D, Stanoev M, Plochev M, Goranov E, Dzhambazov V: [Surgical treatment of pulmonary metastases--surgical methods, early and long-term results]. Khirurgiia (Sofiia); 2008;(3):5-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The primary tumor sites were as follow: colorectal carcinoma--15 (33.3%); renal carcinoma--5 (12.1%); breast carcinoma--6 (13.3%); soft tissue fibrosarcoma--6 (13.3%); osteosarcoma--4 (8.9%); melanoma--1 (2.2%); gastric carcinoma--1 (2.2%), thyreoid gland carcinoma--1 (2.2%); suprarenal carcinoma--1 (2.2%) and carcinoma of salivary gland type--1 (2.2%).
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Humans. Male. Middle Aged. Postoperative Complications / mortality. Prognosis. Retrospective Studies. Sternotomy. Thoracotomy. Young Adult


28. Reiss A, Goldberg Y, Monichor M, Drugan A: Congenital pulmonary myofibroblastic tumor--pathology and prenatal sonographic appearance. Prenat Diagn; 2005 Nov;25(11):1064-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Fetal Diseases / ultrasonography. Fibrosarcoma / ultrasonography. Lung Neoplasms / ultrasonography. Ultrasonography, Prenatal
  • [MeSH-minor] Adult. Female. Humans. Male. Pregnancy

  • MedlinePlus Health Information. consumer health - Fetal Health and Development.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16302162.001).
  • [ISSN] 0197-3851
  • [Journal-full-title] Prenatal diagnosis
  • [ISO-abbreviation] Prenat. Diagn.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] England
  •  go-up   go-down


29. Roll C, Prantl L, Nerlich M, Kinner B: Osteo-fasciocutaneous parascapular flap transfer for reconstruction of the first ray of the foot. Arch Orthop Trauma Surg; 2008 Aug;128(8):857-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adult. Bone Neoplasms / surgery. Female. Fibrosarcoma / surgery. Humans. Male. Middle Aged. Osteomyelitis / etiology. Osteomyelitis / surgery. Reconstructive Surgical Procedures. Young Adult

  • MedlinePlus Health Information. consumer health - Foot Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18297296.001).
  • [ISSN] 0936-8051
  • [Journal-full-title] Archives of orthopaedic and trauma surgery
  • [ISO-abbreviation] Arch Orthop Trauma Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


30. Mankin HJ, Hornicek FJ: Diagnosis, classification, and management of soft tissue sarcomas. Cancer Control; 2005 Jan-Feb;12(1):5-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis, classification, and management of soft tissue sarcomas.
  • BACKGROUND: Soft tissue sarcomas are challenging to oncologists due to their unique character, the infrequency of their occurrence, and the difficulties in predicting outcomes.
  • Patients with leiomyosarcomas, clear cell sarcomas, and malignant fibrous histiocytomas had a poorer survival rate, while those with fibrosarcomas, liposarcomas, and neurofibrosarcomas fared better.
  • [MeSH-major] Sarcoma / diagnosis. Sarcoma / therapy
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. Child. Child, Preschool. Female. Fibrosarcoma / diagnosis. Fibrosarcoma / therapy. Histiocytoma, Benign Fibrous / diagnosis. Histiocytoma, Benign Fibrous / therapy. Humans. Leiomyosarcoma / diagnosis. Leiomyosarcoma / therapy. Liposarcoma / diagnosis. Liposarcoma / therapy. Male. Middle Aged. Neoplasm Staging / methods. Neurofibrosarcoma / diagnosis. Neurofibrosarcoma / therapy. Outcome Assessment (Health Care). Rhabdomyosarcoma / diagnosis. Rhabdomyosarcoma / therapy. Sarcoma, Clear Cell / diagnosis. Sarcoma, Clear Cell / therapy. Sarcoma, Synovial / diagnosis. Sarcoma, Synovial / therapy. Survival Analysis

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15668648.001).
  • [ISSN] 1073-2748
  • [Journal-full-title] Cancer control : journal of the Moffitt Cancer Center
  • [ISO-abbreviation] Cancer Control
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 205
  •  go-up   go-down


31. Huang HY, Brennan MF, Singer S, Antonescu CR: Distant metastasis in retroperitoneal dedifferentiated liposarcoma is rare and rapidly fatal: a clinicopathological study with emphasis on the low-grade myxofibrosarcoma-like pattern as an early sign of dedifferentiation. Mod Pathol; 2005 Jul;18(7):976-84
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The metastatic incidence of retroperitoneal dedifferentiated liposarcoma is comparatively lower than other pleomorphic sarcomas, varying widely from 1 to 18%.
  • Low-grade dedifferentiation resembling low-grade fibrosarcoma has been recently accepted as part of the morphologic spectrum of dedifferentiated liposarcoma and was reported to have similar metastatic and survival rates to its high-grade counterpart.
  • [MeSH-minor] Adult. Aged. Cell Differentiation. Female. Fibrosarcoma / pathology. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Metastasis. Time Factors

  • Genetic Alliance. consumer health - Liposarcoma.
  • Genetic Alliance. consumer health - Retroperitoneal liposarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15832195.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


32. Bianchini L, Maire G, Pedeutour F, Groupe Francophone de Cytogénétique Oncologique: [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors]. Bull Cancer; 2007 Feb;94(2):179-89
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It is also present in variant forms of DP such as giant cell fibroblastoma, Bednar tumor, adult superficial fibrosarcoma and the granular cell variant of DP demonstrating that these tumors are not distinct entities but morphological variants of DP.
  • [MeSH-minor] Adult. Age Factors. Antineoplastic Agents / therapeutic use. Benzamides. Child. Humans. Imatinib Mesylate. Piperazines / therapeutic use. Pyrimidines / therapeutic use. Translocation, Genetic / genetics

  • Genetic Alliance. consumer health - Dermatofibrosarcoma Protuberans.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. IMATINIB MESYLATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17337387.001).
  • [ISSN] 1769-6917
  • [Journal-full-title] Bulletin du cancer
  • [ISO-abbreviation] Bull Cancer
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzamides; 0 / COLIA1-PDGFB fusion protein, human; 0 / Oncogene Proteins, Fusion; 0 / Piperazines; 0 / Pyrimidines; 8A1O1M485B / Imatinib Mesylate
  •  go-up   go-down


33. Meng GZ, Zhang HY, Bu H, Geng JG: Low-grade fibromyxoid sarcoma versus fibromatosis: a comparative study of clinicopathological and immunohistochemical features. Diagn Cytopathol; 2009 Feb;37(2):96-102
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low-grade fibromyxoid sarcoma versus fibromatosis: a comparative study of clinicopathological and immunohistochemical features.
  • We have studied 11 cases of low-grade fibromyxoid sarcoma (LGFMS) and 15 cases of fibromatosis with respect to clinicopathological features and immunohistochemical expression of Ki-67, nm23, cyclinD1, and p53, in order to investigate the differential diagnosis between this two groups.
  • [MeSH-major] Fibroma / diagnosis. Fibrosarcoma / diagnosis. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Cyclin D1 / metabolism. Diagnosis, Differential. Female. Humans. Ki-67 Antigen / metabolism. Male. Middle Aged. NM23 Nucleoside Diphosphate Kinases / metabolism. Neoplasm Staging. Tumor Suppressor Protein p53 / metabolism. Young Adult

  • Genetic Alliance. consumer health - Fibromatosis.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19021197.001).
  • [ISSN] 1097-0339
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / NM23 Nucleoside Diphosphate Kinases; 0 / Tumor Suppressor Protein p53; 136601-57-5 / Cyclin D1; EC 2.7.4.6 / NME1 protein, human
  •  go-up   go-down


34. Battiata AP, Casler J: Sclerosing epithelioid fibrosarcoma: a case report. Ann Otol Rhinol Laryngol; 2005 Feb;114(2):87-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sclerosing epithelioid fibrosarcoma: a case report.
  • Sclerosing epithelioid fibrosarcoma (SEF) is a rare variant of fibrosarcoma.
  • Sclerosing epithelioid fibrosarcoma is a rare neoplasm that is now listed among the low-grade neoplasms that may occur in the head and neck.
  • [MeSH-major] Fibrosarcoma / pathology. Fibrosarcoma / surgery. Head and Neck Neoplasms / pathology. Head and Neck Neoplasms / surgery
  • [MeSH-minor] Adult. Humans. Immunohistochemistry. Magnetic Resonance Imaging. Male

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15757185.001).
  • [ISSN] 0003-4894
  • [Journal-full-title] The Annals of otology, rhinology, and laryngology
  • [ISO-abbreviation] Ann. Otol. Rhinol. Laryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


35. Cappabianca S, Colella G, Russo A, Pezzullo M, Reginelli A, Iaselli F, Rotondo A: Maxillofacial fibrous dysplasia: personal experience with gadoliniumenhanced magnetic resonance imaging. Radiol Med; 2008 Dec;113(8):1198-210
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: The authors sought to identify radiological criteria assisting in the diagnosis of craniofacial fibrous dysplasia and differential diagnosis of fibro-osseous lesions by comparing computed tomography (CT) and magnetic resonance imaging (MRI) findings and histological results in 23 patients with presumed fibrous dysplasia.
  • In one case, targeted biopsy of areas showing intense enhancement led to a diagnosis of low-grade fibrosarcoma; in the remaining two cases, the definitive diagnoses were ossifying fibroma and myeloproliferative disease.
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Female. Humans. Male. Middle Aged. Young Adult

  • Genetic Alliance. consumer health - Fibrous Dysplasia.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Baillieres Best Pract Res Clin Rheumatol. 2000 Jun;14 (2):385-98 [10925751.001]
  • [Cites] Neuroradiology. 1993;35(3):234-7 [8459931.001]
  • [Cites] J Bone Joint Surg Am. 2005 Aug;87(8):1848-64 [16085630.001]
  • [Cites] Radiol Clin North Am. 1993 Jan;31(1):121-34 [8419969.001]
  • [Cites] Clin Radiol. 2004 Jan;59(1):11-25 [14697371.001]
  • [Cites] Radiol Med. 1990 Oct;80(4):441-4 [2244029.001]
  • [Cites] Radiol Clin North Am. 1998 Nov;36(6):1241-59, xii [9884700.001]
  • [Cites] Int J Clin Oncol. 2006 Jun;11(3):229-35 [16850130.001]
  • [Cites] Br J Radiol. 2005 Dec;78(936):1104-15 [16352586.001]
  • [Cites] AJR Am J Roentgenol. 1982 Nov;139(5):943-8 [6981980.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1957 Jan;77(1):71-88 [13381861.001]
  • [Cites] Radiol Med. 1993 Sep;86(3):200-7 [8210526.001]
  • [Cites] J Laryngol Otol. 2001 Sep;115(9):757-9 [11564313.001]
  • [Cites] Cancer. 1994 Mar 1;73(5):1411-24 [8111708.001]
  • (PMID = 18836864.001).
  • [ISSN] 0033-8362
  • [Journal-full-title] La Radiologia medica
  • [ISO-abbreviation] Radiol Med
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Contrast Media; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


36. Marshall KW, Zhang H, Yager TD, Nossova N, Dempsey A, Zheng R, Han M, Tang H, Chao S, Liew CC: Blood-based biomarkers for detecting mild osteoarthritis in the human knee. Osteoarthritis Cartilage; 2005 Oct;13(10):861-71
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Logistic regression analysis identified linear combinations of nine genes--the above six genes, early growth response 1; alpha glucosidase II alpha subunit; and v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)--as discriminatory between subjects with mild OA and controls, with a sensitivity of 86% and specificity of 83% in a training set of 78 samples.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16139532.001).
  • [ISSN] 1063-4584
  • [Journal-full-title] Osteoarthritis and cartilage
  • [ISO-abbreviation] Osteoarthr. Cartil.
  • [Language] ENG
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Validation Studies
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers; 0 / RNA, Messenger
  •  go-up   go-down


37. Bifulco K, De Chiara A, Fazioli F, Longanesi-Cattani I, Cantelmo AR, Tirino V, Apice G, Rocco G, Lombardi ML, Carriero MV: Cell invasiveness in sarcomas: a possibly useful clinical correlation. Tumori; 2008 Jul-Aug;94(4):505-10
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cell invasiveness in sarcomas: a possibly useful clinical correlation.
  • AIMS AND BACKGROUND: The prognosis of each individual patient affected by sarcoma, including those with low histopathologic grading, cannot be reliably predicted at the time of surgery.
  • We have developed an in vitro cell invasion assay on early primary cell cultures derived from surgically removed sarcomas.
  • For each primary cell culture, the sarcoma cell invasion index was determined in comparison with the percentage of human fibrosarcoma HT1080 cell invasion extent.
  • The cell invasion index of 7 different sarcomas was evaluated in respect to the outcome of the disease, after a follow-up ranging from 14 to 48 months.
  • CONCLUSIONS: Our data support the possibility that cell invasion assays performed in vitro on cells derived from human sarcomas may be predictive of a more aggressive form of the disease.
  • [MeSH-major] Sarcoma / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Chondrosarcoma / pathology. Collagen. Disease Progression. Disease-Free Survival. Drug Combinations. Female. Fibroma / pathology. Fibrosarcoma / pathology. Humans. Immunohistochemistry. Laminin. Liposarcoma, Myxoid / pathology. Male. Middle Aged. Neoplasm Invasiveness. Predictive Value of Tests. Prognosis. Proteoglycans. Tumor Cells, Cultured

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18822686.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Drug Combinations; 0 / Laminin; 0 / Proteoglycans; 119978-18-6 / matrigel; 9007-34-5 / Collagen
  •  go-up   go-down


38. Hansen T, Katenkamp K, Brodhun M, Katenkamp D: Low-grade fibrosarcoma--report on 39 not otherwise specified cases and comparison with defined low-grade fibrosarcoma types. Histopathology; 2006 Aug;49(2):152-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low-grade fibrosarcoma--report on 39 not otherwise specified cases and comparison with defined low-grade fibrosarcoma types.
  • AIMS: Low-grade fibrosarcomas are tumours that mainly affect the extremities and trunk of adults of either sex.
  • Among these, low-grade fibromyxoid sarcoma (FMS), hyalinizing spindle cell tumour with giant collagen rosettes (HST) and sclerosing epithelioid fibrosarcoma (SEF) are well-established entities.
  • These low-grade fibrosarcomas, not otherwise specified (FNOS) were provisionally designated as 'fibrosarcoma, low-grade fibroblastic type'.
  • FNOS exhibited increased atypia and mitotic count compared with the other sarcomas studied [FNOS, mean value 4.6 mitoses/10 high-power field (HPF); FMS, 0.7/10 HPF).
  • CONCLUSIONS: The term 'fibrosarcoma, low-grade fibroblastic type' should be used as a diagnosis of exclusion.
  • Further studies should elucidate whether it represents a distinct fibrosarcoma type.
  • [MeSH-major] Fibroblasts / pathology. Fibrosarcoma / pathology
  • [MeSH-minor] Adult. Age Factors. Aged. Aged, 80 and over. Antigens, CD34 / analysis. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Ki-67 Antigen / analysis. Male. Microscopy, Electron. Middle Aged. Neoplasm Recurrence, Local. Terminology as Topic

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16879392.001).
  • [ISSN] 0309-0167
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD34; 0 / Ki-67 Antigen
  •  go-up   go-down


39. Olmos D, Postel-Vinay S, Molife LR, Okuno SH, Schuetze SM, Paccagnella ML, Batzel GN, Yin D, Pritchard-Jones K, Judson I, Worden FP, Gualberto A, Scurr M, de Bono JS, Haluska P: Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study. Lancet Oncol; 2010 Feb;11(2):129-35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study.
  • Preclinical data suggest a dependence on insulin-like growth-factor signalling for sarcoma subtypes, including Ewing's sarcoma, and early reports show antitumour activity of IGF-1R-targeting drugs in these diseases.
  • METHODS: Between January, 2006, and August, 2008, patients with refractory, advanced sarcomas received figitumumab (20 mg/kg) in two single-stage expansion cohorts within a solid-tumour phase 1 trial.
  • The first cohort (n=15) included patients with multiple sarcoma subtypes, age 18 years or older, and the second cohort (n=14) consisted of patients with refractory Ewing's sarcoma, age 9 years or older.
  • FINDINGS: 29 patients, 16 of whom had Ewing's sarcoma, were enrolled and received a total of 177 cycles of treatment (median 2, mean 6.1, range 1-24).
  • Pharmacokinetics were comparable between patients with sarcoma and those with other solid tumours.
  • 28 patients were assessed for response; two patients, both with Ewing's sarcoma, had objective responses (one complete response and one partial response) and eight patients had disease stabilisation (six with Ewing's sarcoma, one with synovial sarcoma, and one with fibrosarcoma) lasting 4 months or longer.
  • INTERPRETATION: Figitumumab is well tolerated and has antitumour activity in Ewing's sarcoma, warranting further investigation in this disease.
  • [MeSH-major] Antibodies, Monoclonal / pharmacokinetics. Antineoplastic Agents / pharmacokinetics. Sarcoma / drug therapy
  • [MeSH-minor] Adolescent. Adult. Child. Cohort Studies. Female. Humans. Immunoglobulins, Intravenous. Male. Middle Aged. Receptor, IGF Type 1 / antagonists & inhibitors. Receptor, IGF Type 1 / immunology. Sarcoma, Ewing / drug therapy. Young Adult


40. Tateishi U, Hasegawa T, Onaya H, Satake M, Arai Y, Moriyama N: Myxoinflammatory Fibroblastic Sarcoma: MR Appearance and Pathologic Correlation. AJR Am J Roentgenol; 2005 Jun;184(6):1749-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Myxoinflammatory Fibroblastic Sarcoma: MR Appearance and Pathologic Correlation.
  • OBJECTIVE: The purpose of our study was to define the MR appearance of myxoinflammatory fibroblastic sarcoma of the soft tissues and to make correlations with the histopathologic features.
  • CONCLUSION: Myxoinflammatory fibroblastic sarcoma is an uncommon malignancy that typically affects adult subjects, who present with painless swelling.
  • [MeSH-major] Fibrosarcoma / pathology. Magnetic Resonance Imaging. Myxosarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / surgery

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15908525.001).
  • [ISSN] 0361-803X
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


41. Chen W, Begum S, Opare-Addo L, Garyu J, Gibson TF, Bothwell AL, Papaioannou VE, Herold KC: Promotion of beta-cell differentiation in pancreatic precursor cells by adult islet cells. Endocrinology; 2009 Feb;150(2):570-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Promotion of beta-cell differentiation in pancreatic precursor cells by adult islet cells.
  • In this study, we tested whether adult islet cells can affect the differentiation process in mouse and human pancreatic anlage cells.
  • We assessed beta-cell proliferation and differentiation in mouse and human pancreatic anlage cells cocultured with adult islet cells or betaTC3 cells using cellular, molecular, and immunohistochemical methods.
  • Human pancreatic anlage cells responded in a similar manner and showed increased expression of pancreatic duodenal homeobox 1 and v-maf musculoaponeurotic fibrosarcoma oncogene homolog A and increased production of proinsulin when cocultured with adult islets.
  • [MeSH-minor] Adult. Animals. Antigens, Surface / physiology. Cell Communication / physiology. Cells, Cultured. Coculture Techniques / methods. Green Fluorescent Proteins / genetics. Humans. Mice. Mice, Inbred BALB C. Mice, Inbred NOD. Mice, SCID. Mice, Transgenic

  • MedlinePlus Health Information. consumer health - Stem Cells.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Invest. 2007 Sep;117(9):2553-61 [17786244.001]
  • [Cites] J Mol Endocrinol. 2000 Jun;24(3):297-302 [10828822.001]
  • [Cites] Stem Cells. 2006 Feb;24(2):258-65 [16109755.001]
  • [Cites] Diabetes. 2001 Feb;50 Suppl 1:S5-9 [11272202.001]
  • [Cites] J Clin Invest. 2007 Jan;117(1):81-3 [17200709.001]
  • [Cites] Transplantation. 2005 May 15;79(9):1091-6 [15880049.001]
  • [Cites] J Cell Sci. 2002 Feb 15;115(Pt 4):753-60 [11865031.001]
  • [Cites] Nature. 2007 Feb 22;445(7130):886-91 [17259975.001]
  • [Cites] Diabetes. 2007 Jul;56(7):1792-801 [17400928.001]
  • [Cites] Nat Med. 2006 Mar;12 (3):310-6 [16491084.001]
  • [Cites] Diabetes. 1995 Mar;44(3):306-13 [7533732.001]
  • [Cites] Endocrinology. 2000 Jun;141(6):1926-9 [10830272.001]
  • [Cites] Transplantation. 2002 Sep 27;74(6):877-9 [12364870.001]
  • [Cites] Mech Dev. 2003 Jan;120(1):35-43 [12490294.001]
  • [Cites] Nat Biotechnol. 2006 Nov;24(11):1392-401 [17053790.001]
  • [Cites] Diabetes. 2005 Oct;54(10):2867-74 [16186387.001]
  • [Cites] Endocrinology. 2000 Jun 1;141(6):1926-1929 [28200925.001]
  • [Cites] Biochem J. 1986 Apr 15;235(2):459-67 [3017307.001]
  • [Cites] BMC Biotechnol. 2004 Dec 24;4:33 [15619330.001]
  • [Cites] Diabetes. 2006 Feb;55(2):269-72 [16361411.001]
  • [Cites] Nature. 1998 Feb 26;391(6670):900-4 [9495343.001]
  • [Cites] Mol Cell Biol. 2005 Jun;25(12):4969-76 [15923615.001]
  • [Cites] J Histochem Cytochem. 2002 Dec;50(12):1625-32 [12486084.001]
  • [Cites] Diabetes. 2003 Mar;52(3):734-40 [12606515.001]
  • [Cites] Nat Biotechnol. 2005 Jul;23(7):857-61 [16003374.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3853-8 [17360442.001]
  • [Cites] Annu Rev Cell Dev Biol. 2003;19:71-89 [14570564.001]
  • [Cites] J Neurosci Res. 2005 May 1;80(3):341-9 [15789407.001]
  • [Cites] Diabetes. 1988 Apr;37(4):413-20 [3288530.001]
  • [Cites] J Pediatr Surg. 1999 May;34(5):689-93; discussion 693-4 [10359165.001]
  • [Cites] Am J Physiol Regul Integr Comp Physiol. 2002 Sep;283(3):R623-30 [12184996.001]
  • [Cites] Nature. 2004 May 6;429(6987):41-6 [15129273.001]
  • [Cites] Genes Dev. 2008 Aug 1;22(15):1998-2021 [18676806.001]
  • [Cites] Diabetes. 1999 May;48(5):989-96 [10331402.001]
  • [Cites] Nat Biotechnol. 2008 Apr;26(4):443-52 [18288110.001]
  • [Cites] Dev Cell. 2006 Mar;10(3):397-405 [16516842.001]
  • [Cites] J Clin Endocrinol Metab. 2002 Oct;87(10):4775-81 [12364473.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2002 Sep;283(3):E413-22 [12169433.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9191-6 [10890921.001]
  • [Cites] J Biol Chem. 2005 Mar 25;280(12):11887-94 [15665000.001]
  • [Cites] Folia Biol (Praha). 2007;53(1):13-22 [17328838.001]
  • [Cites] Diabetes. 2006 Dec;55(12):3238-45 [17130466.001]
  • [Cites] Endocr J. 2008 May;55(2):235-52 [17938503.001]
  • [Cites] J Endocrinol. 2005 Aug;186(2):343-52 [16079260.001]
  • (PMID = 18845629.001).
  • [ISSN] 1945-7170
  • [Journal-full-title] Endocrinology
  • [ISO-abbreviation] Endocrinology
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / R01 DK068661; United States / NIDDK NIH HHS / DK / R01 DK068678
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Surface; 147336-22-9 / Green Fluorescent Proteins
  • [Other-IDs] NLM/ PMC2646532
  •  go-up   go-down


42. Tsuji T, Catasus L, Prat J: Is loss of heterozygosity at 9q22.3 (PTCH gene) and 19p13.3 (STK11 gene) involved in the pathogenesis of ovarian stromal tumors? Hum Pathol; 2005 Jul;36(7):792-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Some ovarian fibromas and rare fibrosarcomas are associated with Gorlin syndrome, which is caused by mutation in the human homologue of Drosophila patched gene (PTCH), localized on chromosome 9q22.3.
  • We have analyzed DNA from 8 fibromas, 6 cellular fibromas, 2 fibrothecomas, 9 luteinized thecomas, and 2 fibrosarcomas of the ovary for LOH at 9q22.3 and 19p13.3, using polymerase chain reaction amplification for 10 microsatellite markers.
  • Allelic losses were not detected in any fibroma, fibrothecoma, or fibrosarcoma.
  • None of the 2 fibrothecomas or 2 fibrosarcomas showed LOH at 19p13.3.
  • [MeSH-minor] Adult. Aged. Basal Cell Nevus Syndrome / genetics. Basal Cell Nevus Syndrome / metabolism. Basal Cell Nevus Syndrome / pathology. Female. Genetic Markers / genetics. Humans. Luteal Cells / metabolism. Luteal Cells / pathology. Lutein / metabolism. Microsatellite Repeats / genetics. Middle Aged. Polymerase Chain Reaction. Protein-Serine-Threonine Kinases / genetics. Protein-Serine-Threonine Kinases / metabolism. Stromal Cells / metabolism. Stromal Cells / pathology

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16084949.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Genetic Markers; 0 / Receptors, Cell Surface; 0 / patched receptors; EC 2.7.1.- / STK11 protein, human; EC 2.7.11.1 / Protein-Serine-Threonine Kinases; X72A60C9MT / Lutein
  •  go-up   go-down


43. Fodor A, Harel C, Fodor L, Armoni M, Salmon P, Trono D, Karnieli E: Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach. Diabetologia; 2007 Jan;50(1):121-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach.
  • AIMS/HYPOTHESIS: We examined a clinical model of ex vivo transdifferentiation of primary adult hepatocytes to insulin-secreting cells for the treatment of type 1 diabetes.
  • The PDX1-transduced hepatocytes expressed several pancreatic transcription factors related to early pancreatic endocrine development (endogenous Pdx1, neurogenic differentiation factor 1 [Neurod1], and NK6 transcription factor related, locus 1 [Nkx6-1]) as well as the late-stage pancreatic transcription factors (paired box gene 4 [Pax4], paired box gene 6 [Pax6], and v-maf musculoaponeurotic fibrosarcoma oncogene homolog A [Mafa]).
  • CONCLUSIONS/INTERPRETATION: Ex vivo lentiviral-mediated PDX1 expression in isolated adult liver cells represents a potential model for type 1 diabetes mellitus therapy.

  • Genetic Alliance. consumer health - Diabetes.
  • MedlinePlus Health Information. consumer health - Genes and Gene Therapy.
  • Hazardous Substances Data Bank. STREPTOZOTOCIN .
  • Hazardous Substances Data Bank. GLUCOSE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 2000 Aug 25;275(34):26050-7 [10862612.001]
  • [Cites] Mol Endocrinol. 2001 Mar;15(3):476-83 [11222748.001]
  • [Cites] Genes Dev. 1998 Jun 15;12(12):1763-8 [9637677.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7999-8004 [10884429.001]
  • [Cites] Science. 2003 Jan 17;299(5605):363 [12532008.001]
  • [Cites] Diabetes. 2004 Dec;53(12):3168-78 [15561947.001]
  • [Cites] Biochem J. 1995 Sep 15;310 ( Pt 3):997-1003 [7575438.001]
  • [Cites] Development. 1996 Mar;122(3):983-95 [8631275.001]
  • [Cites] Mol Ther. 2001 Apr;3(4):584-90 [11319921.001]
  • [Cites] Science. 2001 May 18;292(5520):1389-94 [11326082.001]
  • [Cites] Gene Ther. 2000 Oct;7(20):1744-52 [11083496.001]
  • [Cites] Gene Ther. 1998 Jul;5(7):888-95 [9813659.001]
  • [Cites] Diabetologia. 2003 Jun;46(6):810-21 [12783165.001]
  • [Cites] Blood. 2000 Nov 15;96(10):3392-8 [11071633.001]
  • [Cites] Diabetes. 1996 Nov;45(11):1478-88 [8866550.001]
  • [Cites] Biochem Biophys Res Commun. 2003 Oct 24;310(3):1017-25 [14550306.001]
  • [Cites] Diabetes. 2001 Aug;50(8):1691-7 [11473026.001]
  • [Cites] J Bone Miner Res. 2002 Jun;17(6):1034-43 [12054158.001]
  • [Cites] Nat Med. 2000 Mar;6(3):278-82 [10700229.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 May 31;102(22):7964-9 [15899968.001]
  • [Cites] Mol Endocrinol. 1996 Nov;10(11):1327-34 [8923459.001]
  • [Cites] Nat Med. 2000 May;6(5):568-72 [10802714.001]
  • [Cites] Biotechnol Prog. 1991 May-Jun;7(3):237-45 [1367596.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7253-8 [12756298.001]
  • [Cites] Nat Med. 2003 May;9(5):596-603 [12704384.001]
  • [Cites] J Biol Chem. 2004 Jul 23;279(30):31121-30 [15151993.001]
  • [Cites] Diabetologia. 2005 Oct;48(10):2051-61 [16132961.001]
  • [Cites] Nat Genet. 1997 Jan;15(1):106-10 [8988180.001]
  • [Cites] EMBO J. 1993 Nov;12(11):4251-9 [7901001.001]
  • [Cites] Science. 1996 Apr 12;272(5259):263-7 [8602510.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11400-6 [8876147.001]
  • [Cites] Transplantation. 2002 Dec 27;74(12):1781-7 [12499898.001]
  • [Cites] Hum Gene Ther. 1997 Jul 1;8(10):1195-206 [9215737.001]
  • [Cites] J Biol Chem. 1990 Jun 25;265(18):10173-6 [2191945.001]
  • [Cites] J Biol Chem. 2002 Mar 29;277(13):11225-32 [11781323.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8078-83 [12048252.001]
  • [Cites] Curr Biol. 2003 Jan 21;13(2):105-15 [12546783.001]
  • [Cites] J Virol. 1998 Nov;72(11):8463-71 [9765382.001]
  • [Cites] Hum Gene Ther. 2002 Jan 20;13(2):243-60 [11812281.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Jun 4;318(3):625-30 [15144883.001]
  • [Cites] Mol Ther. 2002 Aug;6(2):199-209 [12161186.001]
  • [Cites] Diabetes. 2000 Feb;49(2):157-62 [10868930.001]
  • [Cites] Nature. 1994 Oct 13;371(6498):606-9 [7935793.001]
  • [Cites] In Vitro Cell Dev Biol. 1986 Apr;22(4):201-11 [2871008.001]
  • [Cites] J Biol Chem. 2003 Aug 22;278(34):31950-7 [12775714.001]
  • [Cites] Methods Cell Biol. 1976;13:29-83 [177845.001]
  • (PMID = 17131142.001).
  • [ISSN] 0012-186X
  • [Journal-full-title] Diabetologia
  • [ISO-abbreviation] Diabetologia
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Homeodomain Proteins; 0 / Insulin; 0 / Trans-Activators; 0 / pancreatic and duodenal homeobox 1 protein; 5W494URQ81 / Streptozocin; IY9XDZ35W2 / Glucose
  •  go-up   go-down


44. Kobayashi E, Kawai A, Endo M, Suehara Y, Takeda K, Nakatani F, Asano T, Sakuraba M, Chuman H, Seki K, Beppu Y: Myxoinflammatory fibroblastic sarcoma. J Orthop Sci; 2008 Nov;13(6):566-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Myxoinflammatory fibroblastic sarcoma.
  • [MeSH-major] Fibrosarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged, 80 and over. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19089546.001).
  • [ISSN] 0949-2658
  • [Journal-full-title] Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
  • [ISO-abbreviation] J Orthop Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


45. Nagata Y, Matsuno T, Hamada N, Shimose S, Arihiro K, Ochi M: Low-grade myofibroblastic sarcoma of the palm. Scand J Plast Reconstr Surg Hand Surg; 2008;42(3):164-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low-grade myofibroblastic sarcoma of the palm.
  • Histologically and immunohistochemically, it was a low-grade myofibroblastic sarcoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18470796.001).
  • [ISSN] 0284-4311
  • [Journal-full-title] Scandinavian journal of plastic and reconstructive surgery and hand surgery
  • [ISO-abbreviation] Scand J Plast Reconstr Surg Hand Surg
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


46. Hassanein AM, Atkinson SP, Al-Quran SZ, Jain SM, Reith JD: Acral myxoinflammatory fibroblastic sarcomas: are they all low-grade neoplasms? J Cutan Pathol; 2008 Feb;35(2):186-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acral myxoinflammatory fibroblastic sarcomas: are they all low-grade neoplasms?
  • Acral myxoinflammatory fibroblastic sarcoma (AMIFS) is a low-grade sarcoma that presents mostly in distal extremities of middle-aged patients.
  • [MeSH-major] Sarcoma / metabolism. Sarcoma / pathology. Soft Tissue Neoplasms / metabolism. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Female. Fibrosarcoma / genetics. Fibrosarcoma / metabolism. Fibrosarcoma / pathology. Foot / pathology. Hand / pathology. Humans. Leg / pathology. Male. Middle Aged


47. Qiu X, Montgomery E, Sun B: Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Hum Pathol; 2008 Jun;39(6):846-56
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
  • Inflammatory myofibroblastic tumor (IMT) and low-grade myofibroblastic sarcoma (LGMS) are intermediate- or low-grade malignant myofibroblastic neoplasms.
  • [MeSH-major] Fibrosarcoma / pathology. Granuloma, Plasma Cell / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Biomarkers, Tumor / metabolism. Child. Child, Preschool. Cytoplasm / ultrastructure. DNA, Neoplasm / analysis. Diagnosis, Differential. Female. Fibroblasts / metabolism. Fibroblasts / ultrastructure. Humans. Immunohistochemistry. In Situ Hybridization, Fluorescence. Infant. Male. Middle Aged. Muscle Fibers, Skeletal / metabolism. Muscle Fibers, Skeletal / ultrastructure. Neoplasm Recurrence, Local. Protein-Tyrosine Kinases / genetics. Protein-Tyrosine Kinases / metabolism. Receptor Protein-Tyrosine Kinases

  • Genetic Alliance. consumer health - Inflammatory myofibroblastic tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18400254.001).
  • [ISSN] 1532-8392
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / DNA, Neoplasm; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.1 / Receptor Protein-Tyrosine Kinases; EC 2.7.10.1 / anaplastic lymphoma kinase
  •  go-up   go-down


48. Alkuwari E, Gravel DH: A 30-year-old man with a soft tissue mass on the right elbow. Inflammatory myxohyaline tumor of the distal extremities with prominent eosinophilic infiltrate. Arch Pathol Lab Med; 2006 Mar;130(3):e35-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Eosinophils / pathology. Fibrosarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Antigens, CD / analysis. Antigens, Differentiation, Myelomonocytic / analysis. Biomarkers, Tumor / analysis. Diagnosis, Differential. Elbow / pathology. Extremities / pathology. Hodgkin Disease / diagnosis. Humans. Inflammation / diagnosis. Male. Sarcoma / diagnosis. Vimentin / analysis

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16519582.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, Differentiation, Myelomonocytic; 0 / Biomarkers, Tumor; 0 / CD68 antigen, human; 0 / Vimentin
  •  go-up   go-down


49. Lee JC, Li CF, Fang FM, Wang JW, Jeng YM, Yu SC, Lin YT, Wu JM, Tsai JW, Li SH, Huang HY: Prognostic implication of MET overexpression in myxofibrosarcomas: an integrative array comparative genomic hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemical analysis. Mod Pathol; 2010 Oct;23(10):1379-92
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chromosome 7 gains are common in some sarcomas, including myxofibrosarcoma, whereas the specific oncogenes are yet to be characterized.
  • [MeSH-major] Biomarkers, Tumor / genetics. Fibrosarcoma / genetics. Proto-Oncogene Proteins c-met / biosynthesis. Receptors, Growth Factor / biosynthesis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Blotting, Western. Chromosomes, Human, Pair 7 / genetics. Comparative Genomic Hybridization. Female. Gene Expression Profiling. Humans. Immunohistochemistry. Kaplan-Meier Estimate. Male. Middle Aged. Oligonucleotide Array Sequence Analysis. Prognosis. Reverse Transcriptase Polymerase Chain Reaction. Up-Regulation. Young Adult

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20639860.001).
  • [ISSN] 1530-0285
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Receptors, Growth Factor; EC 2.7.10.1 / MET protein, human; EC 2.7.10.1 / Proto-Oncogene Proteins c-met
  •  go-up   go-down


50. Meng GZ, Zhang HY, Bu H, Zhang XL, Pang ZG, Ke Q, Liu X, Yang G: Myofibroblastic sarcomas: a clinicopathological study of 20 cases. Chin Med J (Engl); 2007 Mar 5;120(5):363-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Myofibroblastic sarcomas: a clinicopathological study of 20 cases.
  • BACKGROUND: Myofibroblastic sarcoma was used to be a controversial neoplasm.
  • This study investigated the clinicopathological features of 20 cases of myofibroblastic sarcoma arising in different locations.
  • METHODS: The paraffin-embedded tissue samples from 20 cases of patients with myofibroblastic sarcoma were stained immunohistochemically, and 5 cases examined by electron microscopy.
  • Student's t test was used to analyze the difference of Ki-67 labeling index between grade 1 and grade 2 myofibroblastic sarcomas.
  • CONCLUSIONS: Myofibroblastic sarcomas, which exhibit diverse histological appearance, can easily be misdiagnosed as benign tumors.
  • Myofibroblastic sarcomas are local destructive lesions with frequent recurrence, and may metastase distantly.
  • [MeSH-major] Fibrosarcoma / pathology. Myosarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Child. Desmin / analysis. Female. Humans. Immunohistochemistry. Male. Middle Aged. Recurrence

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17376304.001).
  • [ISSN] 0366-6999
  • [Journal-full-title] Chinese medical journal
  • [ISO-abbreviation] Chin. Med. J.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Desmin
  •  go-up   go-down


51. Petrov D, Vlasov V, Stanoev V, Kostadinov M, Danon S, Kirova G: [Results of the operative treatment of primary pulmonary sarcomas]. Khirurgiia (Sofiia); 2008;(1-2):13-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Results of the operative treatment of primary pulmonary sarcomas].
  • OBJECTIVE: To study and evaluate clinic, diagnostics and operative treatment of patients with primary pulmonary sarcomas (PPS).
  • The histological diagnoses were fibrosarcoma (16), fibroleiomyosarcoma (10), leiomyosarcoma (6), rhabdomyosarcoma (7), hemangiopericytoma (3), epitheloid hemangioendothelioma (3), undifferentiated sarcoma (2), malignant schwannoma (1) and liposarcoma (2).
  • [MeSH-major] Lung Neoplasms / surgery. Pulmonary Surgical Procedures / methods. Sarcoma / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Disease-Free Survival. Female. Humans. Male. Middle Aged. Neoplasm Staging. Postoperative Complications / epidemiology. Postoperative Complications / etiology

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18983003.001).
  • [ISSN] 0450-2167
  • [Journal-full-title] Khirurgii︠a︡
  • [ISO-abbreviation] Khirurgiia (Sofiia)
  • [Language] bul
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Bulgaria
  •  go-up   go-down


52. Miller RA, Berger SB, Burke DT, Galecki A, Garcia GG, Harper JM, Sadighi Akha AA: T cells in aging mice: genetic, developmental, and biochemical analyses. Immunol Rev; 2005 Jun;205:94-103
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Some of these QTL have effects that are demonstrable in young-adult mice (8 months of age) and others demonstrable only in middle-aged mice (18 months).
  • Biomarker studies show that T-cell subset levels measured at 8 or 18 months are significant predictors of lifespan for mice dying of lymphoma, fibrosarcoma, mammary adenocarcinoma, or all causes combined.

  • MedlinePlus Health Information. consumer health - Seniors' Health.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15882347.001).
  • [ISSN] 0105-2896
  • [Journal-full-title] Immunological reviews
  • [ISO-abbreviation] Immunol. Rev.
  • [Language] eng
  • [Grant] United States / NIA NIH HHS / AG / AG08808; United States / NIA NIH HHS / AG / AG11687; United States / NIA NIH HHS / AG / AG13283; United States / NIA NIH HHS / AG / AG19619
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.; Review
  • [Publication-country] Denmark
  • [Number-of-references] 34
  •  go-up   go-down


53. Chukwuanukwu TO, Anyanwu SN: Giant fibrosarcoma prostuberans of abodominal wall: management problems in resources-constrained country. Niger J Clin Pract; 2009 Sep;12(3):338-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant fibrosarcoma prostuberans of abodominal wall: management problems in resources-constrained country.
  • BACKGROUND: Abdominal wall sarcomas represent less than 1% of adult malignancies.
  • METHODS: Prospective study of patients with abdominal wall soft tissue sarcoma presenting to the authors.
  • [MeSH-major] Abdominal Neoplasms / diagnosis. Abdominal Neoplasms / surgery. Abdominal Wall / pathology. Abdominal Wall / surgery. Fibrosarcoma / diagnosis. Fibrosarcoma / surgery
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged. Nigeria. Surgical Mesh

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19803041.001).
  • [ISSN] 1119-3077
  • [Journal-full-title] Nigerian journal of clinical practice
  • [ISO-abbreviation] Niger J Clin Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Nigeria
  •  go-up   go-down


54. Saïji E, Guillou L: [Fibroblastic and myofibroblastic tumors of the head and neck]. Ann Pathol; 2009 Sep;29(4):335-46
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This review focuses on several (myo)fibroblastic lesions of the head and neck, including nodular fasciitis and related neoplasms, hemangiopericytoma-like tumor (glomangiopericytoma) of sinonasal passages, nasopharyngeal angiofibroma, desmoid fibromatosis, Gardner-associated fibroma, extrapleural solitary fibrous tumor, inflammatory myofibroblastic tumor, low-grade myofibroblastic sarcoma, and adult-type fibrosarcoma.

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19900638.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 41
  •  go-up   go-down


55. Lang JE, Dodd L, Martinez S, Brigman BE: Case reports: acral myxoinflammatory fibroblastic sarcoma: a report of five cases and literature review. Clin Orthop Relat Res; 2006 Apr;445:254-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Case reports: acral myxoinflammatory fibroblastic sarcoma: a report of five cases and literature review.
  • During the past 2 years, we treated five patients with acral myxoinflammatory fibroblastic sarcoma at our institution.
  • The five patients initially were diagnosed as having benign conditions and treated with intralesional or marginal excision by referring physicians, only to have the lesion reappear as sarcoma.
  • Acral myxoinflammatory fibroblastic sarcoma is a rare, but increasingly recognized sarcoma of the distal extremities, which often is confused with benign lesions.
  • [MeSH-major] Fibrosarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Diagnosis, Differential. Female. Hand / pathology. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Shoulder / pathology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16446594.001).
  • [ISSN] 0009-921X
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 10
  •  go-up   go-down


56. Chidzonga MM, Mahomva L: Sarcomas of the oral and maxillofacial region: a review of 88 cases in Zimbabwe. Br J Oral Maxillofac Surg; 2007 Jun;45(4):317-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sarcomas of the oral and maxillofacial region: a review of 88 cases in Zimbabwe.
  • We reviewed the case notes of 88 patients who were treated for sarcomas of the oral and maxillofacial region over a period of 24 years.
  • [MeSH-major] Jaw Neoplasms / epidemiology. Sarcoma / epidemiology
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Child. Female. Fibrosarcoma / epidemiology. Humans. Male. Mandibular Neoplasms / epidemiology. Maxillary Neoplasms / epidemiology. Middle Aged. Osteosarcoma / epidemiology. Retrospective Studies. Rhabdomyosarcoma / epidemiology. Sex Factors. Zimbabwe / epidemiology

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16386339.001).
  • [ISSN] 0266-4356
  • [Journal-full-title] The British journal of oral & maxillofacial surgery
  • [ISO-abbreviation] Br J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


57. Ozkan B, Ozgüroğlu M, Ozkara H, Durak H, Talat Z: Adult paratesticular myxofibrosarcoma: report of a rare entity and review of the literature. Int Urol Nephrol; 2006;38(1):5-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adult paratesticular myxofibrosarcoma: report of a rare entity and review of the literature.
  • [MeSH-major] Fibrosarcoma / pathology. Genital Neoplasms, Male / pathology. Scrotum

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Urol. 1992 Apr;147(4):1032-6; discussion 1036-7 [1552580.001]
  • [Cites] Am J Surg Pathol. 1996 Apr;20(4):391-405 [8604805.001]
  • [Cites] Acta Pathol Microbiol Immunol Scand Suppl. 1983;282:1-40 [6444190.001]
  • [Cites] Am J Surg Pathol. 1986;10 Suppl 1:14-25 [3296798.001]
  • [Cites] Urology. 2002 Feb;59(2):294-5 [11834406.001]
  • [Cites] Acta Pathol Microbiol Scand A. 1977 Mar;85A(2):127-40 [15396.001]
  • [Cites] Cancer. 1977 Apr;39(4):1672-85 [192434.001]
  • (PMID = 16502045.001).
  • [ISSN] 0301-1623
  • [Journal-full-title] International urology and nephrology
  • [ISO-abbreviation] Int Urol Nephrol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 7
  •  go-up   go-down


58. Elco CP, Mariño-Enríquez A, Abraham JA, Dal Cin P, Hornick JL: Hybrid myxoinflammatory fibroblastic sarcoma/hemosiderotic fibrolipomatous tumor: report of a case providing further evidence for a pathogenetic link. Am J Surg Pathol; 2010 Nov;34(11):1723-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hybrid myxoinflammatory fibroblastic sarcoma/hemosiderotic fibrolipomatous tumor: report of a case providing further evidence for a pathogenetic link.
  • Myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor are rare, slow-growing soft tissue tumors of the distal extremities with recurrent potential.
  • Here we report a case of a 42-year-old female with a soft tissue tumor of the ankle showing hybrid morphologic features of myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor, a der(10)t(1;10), and abnormalities of chromosome 3.
  • [MeSH-major] Chromosomes, Human. Fibrosarcoma / genetics. Hemosiderosis / genetics. Lipoma / genetics. Soft Tissue Neoplasms / genetics
  • [MeSH-minor] Adult. Ankle. Biopsy. Chromosome Aberrations. Chromosomes, Human, Pair 1. Chromosomes, Human, Pair 10. Chromosomes, Human, Pair 3. Female. Humans. Karyotyping. Magnetic Resonance Imaging. Neoadjuvant Therapy. Orthopedic Procedures. Radiotherapy, Adjuvant. Translocation, Genetic. Treatment Outcome

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20871391.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


59. Mine T, Matsueda S, Gao H, Li Y, Wong KK, Peoples GE, Ferrone S, Ioannides CG: Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44 Hi progenitors of taxol-resistant ovarian cancer cells. Oncol Rep; 2010 Jun;23(6):1537-43
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Notch and Hedgehog activate cell-cycle progression of adult and cancer stem cells.
  • Expansion of CD44 High inversely correlated with Jag-1 density on activating autologous tumor and fibrosarcoma cells.
  • [MeSH-major] Antigens, CD44 / metabolism. Drug Resistance, Neoplasm. Fibrosarcoma / metabolism. Ovarian Neoplasms / metabolism. Paclitaxel / pharmacology. RNA, Small Interfering / genetics. Transcription Factors / genetics

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. TAXOL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1680-5 [18230721.001]
  • [Cites] J Cell Biol. 2008 Jan 28;180(2):257-60 [18227277.001]
  • [Cites] Cell. 2008 May 16;133(4):704-15 [18485877.001]
  • [Cites] Cancer Res. 2008 Jun 1;68(11):4311-20 [18519691.001]
  • [Cites] J Biol Chem. 2008 Jun 20;283(25):17635-51 [18441325.001]
  • [Cites] Cancer Immunol Immunother. 2009 Aug;58(8):1185-94 [19048252.001]
  • [Cites] J Immunol. 2002 Oct 1;169(7):3545-54 [12244144.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8 [12629218.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12561-6 [15314219.001]
  • [Cites] Cancer Res. 2005 Apr 1;65(7):2930-7 [15805296.001]
  • [Cites] BMC Cancer. 2005;5:74 [16001973.001]
  • [Cites] Br J Cancer. 2005 Sep 19;93(6):709-18 [16136053.001]
  • [Cites] Cancer Res. 2006 Apr 15;66(8):4182-90 [16618740.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9262-7 [16751266.001]
  • [Cites] Cancer Res. 2006 Jun 15;66(12):6063-71 [16778178.001]
  • [Cites] Clin Cancer Res. 2006 Nov 1;12(21):6557-64 [17085671.001]
  • [Cites] Blood. 2006 Dec 1;108(12):3906-12 [16912222.001]
  • [Cites] Nat Cell Biol. 2006 Dec;8(12):1415-23 [17115028.001]
  • [Cites] Nature. 2006 Dec 21;444(7122):1032-7 [17183313.001]
  • [Cites] Mol Cancer. 2007;6:12 [17274819.001]
  • [Cites] Dev Dyn. 2007 Mar;236(3):886-92 [17295317.001]
  • [Cites] Curr Opin Cell Biol. 2007 Apr;19(2):166-75 [17317139.001]
  • [Cites] Nat Struct Mol Biol. 2007 Apr;14(4):295-300 [17401372.001]
  • [Cites] Clin Pharmacol Ther. 2007 Jun;81(6):893-8 [17460605.001]
  • [Cites] Cancer Res. 2007 Sep 1;67(17):8378-87 [17804754.001]
  • [Cites] Nature. 2007 Sep 20;449(7160):351-5 [17721509.001]
  • [Cites] Nat Rev Genet. 2008 Feb;9(2):115-28 [18202695.001]
  • [Cites] Cell Stem Cell. 2008 Apr 10;2(4):333-44 [18397753.001]
  • (PMID = 20428807.001).
  • [ISSN] 1791-2431
  • [Journal-full-title] Oncology reports
  • [ISO-abbreviation] Oncol. Rep.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P01 CA109688; United States / NCI NIH HHS / CA / R01 CA110249; United States / NCI NIH HHS / CA / R01 CA138188
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antigens, CD44; 0 / Antineoplastic Agents, Phytogenic; 0 / CD44 protein, human; 0 / Calcium-Binding Proteins; 0 / GLI1 protein, human; 0 / Intercellular Signaling Peptides and Proteins; 0 / Membrane Proteins; 0 / RNA, Messenger; 0 / RNA, Small Interfering; 0 / Transcription Factors; 134324-36-0 / Serrate proteins; P88XT4IS4D / Paclitaxel
  • [Other-IDs] NLM/ NIHMS395054; NLM/ PMC3426036
  •  go-up   go-down


60. Kovarik CL, Barrett T, Auerbach A, Cassarino DS: Acral myxoinflammatory fibroblastic sarcoma: case series and immunohistochemical analysis. J Cutan Pathol; 2008 Feb;35(2):192-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acral myxoinflammatory fibroblastic sarcoma: case series and immunohistochemical analysis.
  • BACKGROUND: Acral myxoinflammatory fibroblastic sarcoma (AMFS) is a rare, low-grade neoplasm most often occurring on the extremities of adults.
  • [MeSH-major] Sarcoma / metabolism. Sarcoma / pathology. Soft Tissue Neoplasms / metabolism. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Antigens, CD / biosynthesis. Antigens, CD34 / biosynthesis. Antigens, Differentiation, Myelomonocytic / biosynthesis. Diagnosis, Differential. Female. Fibrosarcoma / metabolism. Fibrosarcoma / pathology. Fingers / pathology. Foot / pathology. Hand / pathology. Humans. Immunohistochemistry. Ki-67 Antigen / biosynthesis. Lymphoma / pathology. Male. Middle Aged. Proto-Oncogene Proteins c-kit / biosynthesis. Receptor, Epidermal Growth Factor / biosynthesis. Receptors, Cell Surface / biosynthesis. Toes / pathology. Tumor Suppressor Protein p53 / biosynthesis

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18190444.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, CD34; 0 / Antigens, Differentiation, Myelomonocytic; 0 / CD163 antigen; 0 / Ki-67 Antigen; 0 / Receptors, Cell Surface; 0 / Tumor Suppressor Protein p53; EC 2.7.10.1 / EGFR protein, human; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit; EC 2.7.10.1 / Receptor, Epidermal Growth Factor
  •  go-up   go-down


61. Kakuta Y, Kobayashi Y, Katoh T, Saitoh J, Yazawa K, Hosomi M, Itoh K: [Three cases of retroperitoneal soft tissue sarcoma]. Hinyokika Kiyo; 2006 Apr;52(4):271-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Three cases of retroperitoneal soft tissue sarcoma].
  • Soft tissue sarcomas (STS) are rare tumors that comprise only 1% of all malignancies.
  • Histologically, it was fibrosarcoma 3,000 g in weight.
  • It was undifferentiated sarcoma 2,000 g in weight.
  • [MeSH-major] Retroperitoneal Neoplasms / radiography. Sarcoma / radiography. Soft Tissue Neoplasms / radiography
  • [MeSH-minor] Adult. Aged. Female. Fibrosarcoma / radiography. Fibrosarcoma / surgery. Humans. Liposarcoma / radiography. Liposarcoma / surgery. Male. Prognosis. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16686354.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


62. Sassi SH, Dhouib R, Ben Dhaou S, Mrad K, Driss M, Abbes I, Arbi H, Haourai H, Ben Romdhane K: [Sclerosing epithelioid fibrosarcoma. A case report]. Rev Chir Orthop Reparatrice Appar Mot; 2008 Feb;94(1):92-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Sclerosing epithelioid fibrosarcoma. A case report].
  • Sclerosing epithelioid fibrosarcoma is a rare variant of fibrosarcomas, which was recently identified as a separate entity due to specific histologic and immunohistochemistry features and its poor prognosis.
  • We report a case of sclerosing epithelioid fibrosarcoma of soft tissues, which developed in a 37-year-old woman who presented a tumor involving the posteromedial aspect of the left knee and which progressed in size for one year.
  • Histology of the tumorectomy specimen and the immunohistochemistry study led to the diagnosis of sclerosing epithelioid fibrosarcoma of soft tissues.
  • [MeSH-major] Fibrosarcoma / diagnosis. Knee. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Adult. Female. Humans

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18342037.001).
  • [ISSN] 0035-1040
  • [Journal-full-title] Revue de chirurgie orthopédique et réparatrice de l'appareil moteur
  • [ISO-abbreviation] Rev Chir Orthop Reparatrice Appar Mot
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


63. Talbot SG, Mehrara BJ, Disa JJ, Wong AK, Pusic A, Cordeiro PG, Athanasian EA: Soft-tissue coverage of the hand following sarcoma resection. Plast Reconstr Surg; 2008 Feb;121(2):534-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Soft-tissue coverage of the hand following sarcoma resection.
  • BACKGROUND: Hand-sparing surgery is now the most common option for sarcomas of the hand.
  • The authors review the experience at a single institution of hand reconstruction following sarcoma resection based on prospectively collected data.
  • METHODS: Data were collected for all patients undergoing sarcoma resection by a single surgeon.
  • The most common abnormalities were epithelioid sarcoma (n = 9), soft-tissue malignant fibrous histiocytoma (n = 8), synovial sarcoma (n = 6), and fibrosarcoma (n = 4).
  • CONCLUSIONS: The choice of hand reconstruction method following sarcoma resection depends on a complete knowledge of options, risks, and benefits.
  • [MeSH-major] Hand. Reconstructive Surgical Procedures / methods. Sarcoma / surgery. Soft Tissue Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Amputation / methods. Biopsy. Child. Child, Preschool. Female. Follow-Up Studies. Humans. Infant. Male. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Neoplasm Staging. Retrospective Studies. Surgical Flaps. Survival Rate. Treatment Outcome. United States / epidemiology


64. Bahrami A, Folpe AL: Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. Am J Surg Pathol; 2010 Oct;34(10):1504-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period.
  • Adult-type fibrosarcoma (FS) was once considered the most common adult sarcoma, but is now considered a diagnosis of exclusion.
  • One hundred ninety-five cases diagnosed as adult FS in somatic soft tissue were retrieved from our institutional archives for the period 1960 to 2008.
  • Fluorescence in situ hybridization analysis for SYT gene rearrangement was done in 6 putative CK-negative synovial sarcomas (SS).
  • Non-FS (137 cases) were reclassified as: undifferentiated pleomorphic sarcoma (32 cases), SS (21 cases), solitary fibrous tumor (14 cases), myxofibrosarcoma (11 cases), malignant peripheral nerve sheath tumor (8 cases), FS dermatofibrosarcoma protuberans, and desmoplastic melanoma (4 cases each), low-grade fibromyxoid sarcoma, sarcomatoid carcinoma, desmoid-type fibromatosis, rhabdomyosarcoma, myofibroblastic sarcoma, spindle-cell liposarcoma (3 cases each), sclerosing epithelioid FS, fibroma-like epithelioid sarcoma, leiomyosarcoma, cellular fibrous histiocytoma (2 cases each), and others (17 cases).
  • Exclusive of undifferentiated pleomorphic sarcoma, the distinction of which from FS is subjective, 64% of putative FS were reclassified, most commonly as monophasic SS and solitary fibrous tumor.
  • We conclude that true FS is exceedingly rare, accounting for <1% of approximately 10,000 adult soft tissue sarcomas seen at our institution during this time period, and should be diagnosed with great caution.
  • [MeSH-major] Fibrosarcoma / diagnosis. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. Biomarkers, Tumor / metabolism. Child. Child, Preschool. DNA, Neoplasm / analysis. Female. Gene Rearrangement. Humans. In Situ Hybridization, Fluorescence. Male. Middle Aged. Minnesota / epidemiology. Proto-Oncogene Proteins / genetics. Proto-Oncogene Proteins / metabolism. Repressor Proteins / genetics. Repressor Proteins / metabolism. Young Adult


65. Davidović LB, Sindjelić RB, Savić NB, Kostić DM, Svetković SD, Kuzmanović IB, Marković DM, Marković MM, Cinara IS, Maksimović ZL: [Surgical treatment of abdominal tumours closely related to major blood vessels]. Srp Arh Celok Lek; 2008 May-Jun;136(5-6):241-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Histologically, the most frequent were the following: renal carcinoma in 14 patients, teratoma in 7, liposarcoma in 5, fibrosarcoma and lymphoma in 3 patients.
  • [MeSH-minor] Adolescent. Adult. Aged. Blood Vessel Prosthesis Implantation. Child. Female. Humans. Male. Middle Aged. Neoplasm Invasiveness

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18792619.001).
  • [ISSN] 0370-8179
  • [Journal-full-title] Srpski arhiv za celokupno lekarstvo
  • [ISO-abbreviation] Srp Arh Celok Lek
  • [Language] srp
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Serbia
  •  go-up   go-down


66. Kalapurakal JA, Goldman S, Stellpflug W, Curran J, Sathiaseelan V, Marymont MH, Tomita T: Phase I study of intraoperative radiotherapy with photon radiosurgery system in children with recurrent brain tumors: preliminary report of first dose level (10 Gy). Int J Radiat Oncol Biol Phys; 2006 Jul 1;65(3):800-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adolescent. Adult. Brain / pathology. Brain / radiation effects. Child. Ependymoma / radiotherapy. Ependymoma / surgery. Feasibility Studies. Female. Fibrosarcoma / radiotherapy. Fibrosarcoma / surgery. Humans. Intraoperative Period. Male. Maximum Tolerated Dose. Necrosis / etiology. Radiation Injuries / etiology. Radiosurgery / instrumentation. Radiotherapy Dosage

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16580791.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


67. Katabathina VS, Vikram R, Nagar AM, Tamboli P, Menias CO, Prasad SR: Mesenchymal neoplasms of the kidney in adults: imaging spectrum with radiologic-pathologic correlation. Radiographics; 2010 Oct;30(6):1525-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Malignant renal tumors of mesenchymal origin include leiomyosarcoma, rhabdomyosarcoma, angiosarcoma, osteosarcoma, synovial sarcoma, fibrosarcoma, malignant fibrous histiocytoma, and solitary fibrous tumor.
  • Although osteosarcoma may demonstrate characteristic dense ossification, most renal sarcomas demonstrate imaging features that are indistinguishable from the more common renal cell carcinoma.
  • [MeSH-minor] Adult. Biopsy. Diagnosis, Differential. Humans

  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © RSNA, 2010.
  • (PMID = 21071373.001).
  • [ISSN] 1527-1323
  • [Journal-full-title] Radiographics : a review publication of the Radiological Society of North America, Inc
  • [ISO-abbreviation] Radiographics
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


68. Jin Z, Lahat G, Korchin B, Nguyen T, Zhu QS, Wang X, Lazar AJ, Trent J, Pollock RE, Lev D: Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target. Clin Cancer Res; 2008 Aug 15;14(16):5033-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target.
  • PURPOSE: New therapeutic targets for soft-tissue sarcoma (STS) treatment are critically needed.
  • Midkine (MK), a multifunctional cytokine, is expressed during midgestation but is highly restricted in normal adult tissues.
  • The growth of parental versus MK-transfected human fibrosarcoma cells was studied in vivo.
  • [MeSH-major] Cytokines / metabolism. Sarcoma / metabolism. Sarcoma / pathology. Soft Tissue Neoplasms / metabolism. Soft Tissue Neoplasms / pathology

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18698021.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cytokines; 0 / Low Density Lipoprotein Receptor-Related Protein-1; 0 / Membrane Glycoproteins; 0 / Receptors, Growth Factor; 0 / midkine receptors; 137497-38-2 / midkine; EC 3.1.3.48 / Protein Tyrosine Phosphatases
  •  go-up   go-down


69. Van Winkle P, Angiolillo A, Krailo M, Cheung YK, Anderson B, Davenport V, Reaman G, Cairo MS: Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience. Pediatr Blood Cancer; 2005 Apr;44(4):338-47
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience.
  • BACKGROUND: The prognosis for children with recurrent/refractory sarcomas is poor.
  • We determined the overall response rate (ORR) and overall survival (OS) of children with recurrent/refractory sarcomas who were given ifosfamide, carboplatin, and etoposide (ICE) in three Children's Cancer Group (CCG) phase I/II trials.
  • PROCEDURE: Children with recurrent/refractory sarcoma were treated with ifosfamide (1,800 mg/m2/day on day 0-4), carboplatin (400 mg/m2/day on day 0-1), etoposide (100 mg/m2/day on day 0-4) and either rhG-CSF (10 microg/kg/day vs. 5 microg/kg/day, CCG-0894, 71 patients), PIXY321 (500-1,000 microg/m2/day, CCG-0924, 14 patients), or rhG-CSF (5 microg/kg/day) and IL-6 (2.5-5 microg/kg/day, CCG-0931, 12 patients).
  • Tumor types were osteosarcoma (OTS) (n = 34), rhabdomyosarcoma (n = 27), Ewing sarcoma (EWS) (n = 21), soft tissue sarcoma-not otherwise specified (n = 5), undifferentiated sarcoma (n = 6), fibrosarcoma (n = 2), peripheral primitive neuroectodermal tumor (n = 1), and extraosseous Ewing (n = 1).
  • CONCLUSIONS: The ORR to ICE reinduction chemotherapy in children with recurrent/refractory sarcoma was 51%.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Sarcoma / drug therapy
  • [MeSH-minor] Adolescent. Adult. Carboplatin / administration & dosage. Child. Child, Preschool. Colony-Stimulating Factors / administration & dosage. Etoposide / administration & dosage. Female. Humans. Ifosfamide / administration & dosage. Male. Multivariate Analysis. Proportional Hazards Models. Recurrence. Rhabdomyosarcoma / drug therapy. Rhabdomyosarcoma / mortality. Survival Rate

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • Hazardous Substances Data Bank. CARBOPLATIN .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15503297.001).
  • [ISSN] 1545-5009
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Colony-Stimulating Factors; 6PLQ3CP4P3 / Etoposide; BG3F62OND5 / Carboplatin; UM20QQM95Y / Ifosfamide
  •  go-up   go-down


70. Gesslein J, Koch T, Brucker C: [Fibrosarcoma of the female breast]. MMW Fortschr Med; 2007 Aug 16;149(33-34):38-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Fibrosarcoma of the female breast].
  • [MeSH-major] Breast Neoplasms. Fibrosarcoma
  • [MeSH-minor] Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Breast / pathology. Chemotherapy, Adjuvant. Female. Follow-Up Studies. Humans. Lung Neoplasms / secondary. Mammography. Mastectomy, Radical. Mastectomy, Segmental. Neoplasm Recurrence, Local. Neoplasm Staging. Phyllodes Tumor / surgery. Prognosis. Time Factors. Ultrasonography, Mammary

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17912865.001).
  • [ISSN] 1438-3276
  • [Journal-full-title] MMW Fortschritte der Medizin
  • [ISO-abbreviation] MMW Fortschr Med
  • [Language] ger
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 0
  •  go-up   go-down


71. Kalebi AY, Hale MJ: Pulmonary metastasis from a deltoid subcutaneous low-grade fibromyxoid sarcoma with giant collagen rosettes. Hum Pathol; 2008 Oct;39(10):1553-4; author reply 1554
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pulmonary metastasis from a deltoid subcutaneous low-grade fibromyxoid sarcoma with giant collagen rosettes.
  • [MeSH-major] Fibrosarcoma / diagnosis. Heart Neoplasms / diagnosis. Lung Neoplasms / diagnosis
  • [MeSH-minor] Adult. Collagen. Female. Humans. Muscle, Skeletal / pathology. Soft Tissue Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Hum Pathol. 2008 Apr;39(4):623-8 [18275982.001]
  • (PMID = 18774378.001).
  • [ISSN] 1532-8392
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Comment; Letter
  • [Publication-country] United States
  • [Chemical-registry-number] 9007-34-5 / Collagen
  •  go-up   go-down


72. Huber GF, Matthews TW, Dort JC: Radiation-induced soft tissue sarcomas of the head and neck. J Otolaryngol; 2007 Apr;36(2):93-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiation-induced soft tissue sarcomas of the head and neck.
  • PURPOSE: To describe the occurrence of radiation-induced soft tissue sarcomas in a retrospectively analyzed cohort of patients.
  • PATIENTS AND METHODS: While performing a retrospective analysis of soft tissue sarcomas in patients treated between 1974 and 1999 at the two major cancer centres in Alberta (Canada), eight patients presenting with nine sarcomas occurring in a previously radiated site were identified.
  • Eight fulfilled the criteria for radiation-induced sarcoma.
  • RESULTS: Radiation-induced sarcomas occurred between 10 months and more than 50 years after irradiation (median 7.35 years).
  • Patients' ages ranged from 36 to 88 years (median 77.3 years) at the time of their sarcoma diagnosis.
  • Histologically, four malignant fibrous histiocytomas, two dermatofibrosarcoma protuberans, two carcinosarcomas, and one fibrosarcoma were diagnosed.
  • Radiation-induced sarcomas are associated with poor overall prognosis.
  • The population at risk for the development of radiation-induced sarcoma is increasing, so vigilance is required in the follow-up of those patients.
  • [MeSH-major] Head and Neck Neoplasms / etiology. Head and Neck Neoplasms / pathology. Neoplasms, Radiation-Induced / etiology. Neoplasms, Radiation-Induced / pathology. Sarcoma / etiology. Sarcoma / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17459279.001).
  • [ISSN] 0381-6605
  • [Journal-full-title] The Journal of otolaryngology
  • [ISO-abbreviation] J Otolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  •  go-up   go-down


73. Buccoliero AM, Castiglione F, Rossi Degl'Innocenti D, Maio V, Taddei A, Sardi I, Noccioli B, Franchi A, Taddei GL: Congenital/Infantile fibrosarcoma of the colon: morphologic, immunohistochemical, molecular, and ultrastructural features of a relatively rare tumor in an extraordinary localization. J Pediatr Hematol Oncol; 2008 Oct;30(10):723-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Congenital/Infantile fibrosarcoma of the colon: morphologic, immunohistochemical, molecular, and ultrastructural features of a relatively rare tumor in an extraordinary localization.
  • Fibrosarcomas diagnosed during the early years of life are called congenital/infantile fibrosarcomas.
  • They differ from adult fibrosarcomas because of their limited aggressive outcome.
  • Congenital/infantile fibrosarcomas occur most frequently on the extremities.
  • This article describes an exceptional case of colonic congenital/infantile fibrosarcoma diagnosed in a 3-day-old baby boy.
  • It is the third intestinal congenital/infantile fibrosarcoma reported in the international literature.
  • The algorithm for the diagnosis of congenital/infantile fibrosarcoma, especially outside the usual localizations, should comprise morphologic, immunohistochemical, molecular, and ultrastructural studies.
  • [MeSH-major] Colonic Neoplasms / congenital. Fibrosarcoma / congenital

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19011467.001).
  • [ISSN] 1536-3678
  • [Journal-full-title] Journal of pediatric hematology/oncology
  • [ISO-abbreviation] J. Pediatr. Hematol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


74. Kobayashi K, Murakami R, Fujii T, Hirano A: Malignant transformation of ameloblastic fibroma to ameloblastic fibrosarcoma: case report and review of the literature. J Craniomaxillofac Surg; 2005 Oct;33(5):352-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant transformation of ameloblastic fibroma to ameloblastic fibrosarcoma: case report and review of the literature.
  • INTRODUCTION: Ameloblastic fibrosarcoma is a rare malignant odontogenic tumour and is regarded as the malignant counterpart of the ameloblastic fibroma.
  • PATIENT: The case of a 26-year-old man who underwent curettage of an ameloblastic fibroma and died of an ameloblastic fibrosarcoma is presented, and the course of malignant transformation is analysed retrospectively.
  • CONCLUSION: One-third of ameloblastic fibrosarcoma cases seem to have developed from recurrent ameloblastic fibromas.
  • Knowledge of the malignant potential in the mesenchymal spindle cells of ameloblastic fibroma will assist in determining the management of these benign tumours, and may prevent malignant transformation to ameloblastic fibrosarcoma.
  • [MeSH-minor] Adult. Fatal Outcome. Follow-Up Studies. Fractures, Spontaneous / pathology. Humans. Male. Mandibular Fractures / pathology. Neoplasm Recurrence, Local / pathology

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16129612.001).
  • [ISSN] 1010-5182
  • [Journal-full-title] Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
  • [ISO-abbreviation] J Craniomaxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Scotland
  • [Number-of-references] 16
  •  go-up   go-down


75. Cecchetto G, Alaggio R, Dall'Igna P, Bisogno G, Ferrari A, Gigante C, Casanova M, Sotti G, Zanetti I, Carli M: Localized unresectable non-rhabdo soft tissue sarcomas of the extremities in pediatric age: results from the Italian studies. Cancer; 2005 Nov 1;104(9):2006-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Localized unresectable non-rhabdo soft tissue sarcomas of the extremities in pediatric age: results from the Italian studies.
  • BACKGROUND: Treatment of initially unresectable nonrhabdo soft tissue sarcomas (NRSTS) in pediatric age is debated, due to their different chemosensitivity.
  • Chemosensitive (CTs) sarcomas, 21: synovial sarcoma, 11; extraosseous Ewing sarcomas, 5; primitive peripheral neuroectodermic tumors, 5.
  • Nonchemosensitive (CTns) sarcomas, 31: fibrosarcoma, 11; malignant peripheral nerve sheet tumors, 10; liposarcoma, 2; hemangiopericitoma adult type, 2; epithelioid sarcoma, 2; and alveolar soft part sarcoma, leiomyosarcoma, clear cell sarcoma, and sarcoma NOS, each 1.
  • Tumor size < 5 cm, distal site, and tumor grading for CTns sarcomas were often linked to a favorable outcome; no conclusive results were detected concerning age of the patients or T status of the tumor.
  • [MeSH-major] Extremities. Sarcoma / diagnosis

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2005 American Cancer Society.
  • (PMID = 16161038.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


76. Scottish Bone Tumor Registry, Sharma H, Mehdi SA, MacDuff E, Reece AT, Jane MJ, Reid R: Paget sarcoma of the spine: Scottish Bone Tumor Registry experience. Spine (Phila Pa 1976); 2006 May 20;31(12):1344-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paget sarcoma of the spine: Scottish Bone Tumor Registry experience.
  • STUDY DESIGN: Retrospective case study of 13 cases of Paget sarcoma of the spine accrued from a prospectively collected Tumor Registry database.
  • OBJECTIVES: To analyze the clinical, radiologic, and histologic features of Paget sarcoma of the spine and to determine the factors influencing the prognosis.
  • There is very little in the literature with regard to clinical presentation and prognosis of patients with Paget sarcoma affecting the vertebral column.
  • METHODS: Between January 1944 and December 2003, 89 patients were registered with a diagnosis of Paget sarcoma in the Scottish Bone Tumor Registry.
  • Thirteen patients with Paget sarcoma of the spine were analyzed with regard to their clinical, radiologic, and histopathologic features along with the prognostic predictors.
  • The rest were chondrosarcoma (n = 1), fibrosarcoma (n = 1), and malignant fibrous histiocytoma (n = 1).
  • CONCLUSIONS: This series confirmed that Paget sarcoma of the spine has a very poor prognosis.
  • There was no significant difference observed on the overall prognosis of the patients with Paget sarcoma of the spine in the last 6 decades.
  • [MeSH-major] Lumbar Vertebrae. Osteitis Deformans. Sacrum. Sarcoma. Spinal Neoplasms
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Nerve Compression Syndromes / complications. Nerve Compression Syndromes / etiology. Nervous System Diseases / etiology. Registries. Retrospective Studies. Spinal Cord Compression / complications. Spinal Cord Compression / etiology. Spinal Nerve Roots. Survival Analysis. Tomography, X-Ray Computed


77. Jakowski JD, Wakely PE Jr: Primary intrathoracic low-grade fibromyxoid sarcoma. Hum Pathol; 2008 Apr;39(4):623-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary intrathoracic low-grade fibromyxoid sarcoma.
  • Low-grade fibromyxoid sarcoma (LGFMS) is a rare neoplasm commonly affecting young adults and typically arising in the somatic soft tissue of the proximal extremities.
  • Diagnosis was aided by a strikingly characteristic light microscopic appearance of a bland spindle cell sarcoma containing numerous so-called giant collagen rosettes and supported by immunohistology, evidence of FUS translocation by fluorescence in situ hybridization, and electron microscopy demonstrating a fibroblastic phenotype.
  • Low-grade fibromyxoid sarcoma is probably an underrecognized intrathoracic neoplasm and should be considered in the differential diagnosis of spindle cell neoplasms of the mediastinum, pleura, heart, and lungs.
  • [MeSH-major] Fibrosarcoma / diagnosis. Heart Neoplasms / diagnosis
  • [MeSH-minor] Adult. Female. Humans. In Situ Hybridization, Fluorescence. Male. Microscopy, Electron. Middle Aged. RNA-Binding Protein FUS / genetics. Translocation, Genetic

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Hum Pathol. 2008 Oct;39(10):1553-4; author reply 1554 [18774378.001]
  • (PMID = 18275982.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA-Binding Protein FUS
  • [Number-of-references] 30
  •  go-up   go-down


78. Kleinerman RA, Tucker MA, Abramson DH, Seddon JM, Tarone RE, Fraumeni JF Jr: Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst; 2007 Jan 3;99(1):24-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
  • BACKGROUND: Survivors of hereditary retinoblastoma have an increased risk for second malignancies, especially soft tissue sarcomas.
  • However, the risks of individual histologic subtypes of soft tissue sarcomas have not been evaluated.
  • METHODS: We estimated the risk for six subtypes of soft tissue sarcomas (fibrosarcoma, liposarcoma, histiocytoma, leiomyosarcoma, rhabdomyosarcoma, and others) in a cohort of 963 one-year survivors of hereditary retinoblastoma among patients diagnosed at two US institutions from 1914 through 1984.
  • We calculated standardized incidence ratios (SIRs) for specific subtypes of soft tissue sarcomas by comparison with population data from the Connecticut Tumor Registry or from National Cancer Institute Surveillance, Epidemiology, and End Results database.
  • We also calculated the cumulative risk for all soft tissue sarcomas combined.
  • RESULTS: We observed 69 soft tissue sarcomas in 68 patients with hereditary retinoblastoma.
  • Risks were elevated for soft tissue sarcomas overall (SIR = 184, 95% confidence interval [CI] = 143 to 233) and for individual subtypes.
  • Among patients treated with radiotherapy for retinoblastoma, we found statistically significantly increased risks of soft tissue sarcomas in the field of radiation.
  • Irradiated patients also had increased risks of soft tissue sarcomas, especially leiomyosarcomas, outside the field of radiation, and risks of soft tissue sarcomas were increased in nonirradiated patients as well, indicating a genetic predisposition to soft tissue sarcomas independent of radiation.
  • The cumulative risk for any soft tissue sarcoma 50 years after radiotherapy for retinoblastoma was 13.1% (95% CI = 9.7% to 17.0%).
  • CONCLUSION: Long-term follow-up of a cohort of survivors of hereditary retinoblastoma revealed a statistically significant excess of leiomyosarcoma and other soft tissue sarcomas that persists decades after the retinoblastoma diagnosis.
  • Retinoblastoma survivors should undergo regular medical surveillance for sarcomas in their adult years.
  • [MeSH-major] Neoplasms, Second Primary / epidemiology. Neoplasms, Second Primary / etiology. Population Surveillance. Retinoblastoma / genetics. Sarcoma / epidemiology. Sarcoma / etiology. Survivors / statistics & numerical data
  • [MeSH-minor] Adult. Aged. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Chemotherapy, Adjuvant. Child. Child, Preschool. Confounding Factors (Epidemiology). Female. Humans. Incidence. Infant. Leiomyosarcoma / epidemiology. Leiomyosarcoma / etiology. Male. Middle Aged. Odds Ratio. Radiotherapy / adverse effects. Radiotherapy, Adjuvant / adverse effects. Registries. Retinal Neoplasms / genetics. Risk Assessment. SEER Program. United States / epidemiology

  • Genetic Alliance. consumer health - Retinoblastoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Natl Cancer Inst. 2007 Jan 3;99(1):3-5 [17202103.001]
  • (PMID = 17202110.001).
  • [ISSN] 1460-2105
  • [Journal-full-title] Journal of the National Cancer Institute
  • [ISO-abbreviation] J. Natl. Cancer Inst.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  •  go-up   go-down


79. Collini P, Sorensen PH, Patel S, Blay JY, Issels RD, Maki RG, Eriksson M, del Muro XG: Sarcomas with spindle cell morphology. Semin Oncol; 2009 Aug;36(4):324-37
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sarcomas with spindle cell morphology.
  • In the days before the term "high-grade undifferentiated pleomorphic sarcoma" came into use, one of the most common sarcoma diagnoses was "malignant fibrous histiocytoma," and before that, in an era before immunohistochemistry, "fibrosarcoma" was used to describe most sarcomas.
  • "Spindle cell" is a descriptive phrase that denotes the cellular shape of many of the sarcomas encountered in the adult population.
  • As a result, they are usually treated differently from small round cell sarcomas, and have different biological characteristics than those tumors and sarcomas with epithelioid morphology.
  • As a very broad generalization, sarcomas with a spindle cell microscopic morphology occur in adults and are treated primarily with surgery and often adjuvant or neoadjuvant radiation as primary therapy.
  • In comparison to small round cell sarcomas such as Ewing sarcoma, the use of adjuvant chemotherapy remains controversial, and the sensitivity of these tumors to chemotherapy in the metastatic setting is highly variable.
  • In this article, we describe some of the clinical and biological characteristics of this group of sarcomas.
  • [MeSH-major] Sarcoma / pathology
  • [MeSH-minor] Chemotherapy, Adjuvant. Fibrosarcoma / genetics. Fibrosarcoma / pathology. Gene Fusion. Heat-Shock Response. Humans. Hyperthermia, Induced. Protein Kinase Inhibitors / therapeutic use. Sarcoma, Synovial / genetics. Sarcoma, Synovial / pathology. Translocation, Genetic

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19664493.001).
  • [ISSN] 0093-7754
  • [Journal-full-title] Seminars in oncology
  • [ISO-abbreviation] Semin. Oncol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA47179
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Protein Kinase Inhibitors
  • [Number-of-references] 62
  •  go-up   go-down


80. Adeleye AO, Fellig Y, Umansky F, Shoshan Y: Rapid growth of primary cerebral fibrosarcoma with conversion to glioblastoma at second recurrence. J Neurooncol; 2009 Apr;92(2):233-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rapid growth of primary cerebral fibrosarcoma with conversion to glioblastoma at second recurrence.
  • We present a case of de novo fibrosarcoma in a 43-year-old male, with MRI documented evolution from a 5 mm hyperintense area to 5 cm tumor mass in a 12-month period.
  • The diagnosis of low-grade fibrosarcoma was established by three experienced neuropathologists.
  • [MeSH-major] Brain Neoplasms / pathology. Fibrosarcoma / pathology. Glioblastoma / pathology. Neoplasms, Second Primary / pathology
  • [MeSH-minor] Adult. Combined Modality Therapy. Humans. Magnetic Resonance Imaging. Male. Neurosurgical Procedures. Radiosurgery. Radiotherapy, Conformal

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • Genetic Alliance. consumer health - Glioblastoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1969 Aug;24(2):270-6 [4307749.001]
  • [Cites] Cancer. 1995 Jun 15;75(12):2910-8 [7773942.001]
  • [Cites] Surg Neurol. 2003 Dec;60(6):579-83; discussion 583-4 [14670686.001]
  • [Cites] Cancer. 1993 Dec 1;72(11):3277-81 [8242554.001]
  • [Cites] Am J Surg Pathol. 2002 Aug;26(8):1056-63 [12170093.001]
  • [Cites] Pediatr Neurosurg. 2000 Nov;33(5):257-260 [11155063.001]
  • [Cites] Childs Nerv Syst. 2002 Nov;18(11):648-51 [12420128.001]
  • [Cites] Acta Neuropathol. 1973;23(4):334-7 [4718200.001]
  • [Cites] Neurosurgery. 1995 Apr;36(4):685-90 [7596497.001]
  • [Cites] Cancer. 1979 Jan;43(1):246-57 [216476.001]
  • [Cites] Acta Neurochir (Wien). 1997;139(7):684-9 [9265963.001]
  • [Cites] J Neurooncol. 2004 Jun;68(2):161-7 [15218953.001]
  • [Cites] J Neurosurg. 1989 Jul;71(1):77-82 [2661743.001]
  • (PMID = 19082530.001).
  • [ISSN] 1573-7373
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


81. Willems SM, Debiec-Rychter M, Szuhai K, Hogendoorn PC, Sciot R: Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model. Mod Pathol; 2006 Mar;19(3):407-16
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A number of sarcomas are characterised by specific cytogenetic aberrations, giving not only insight in their biological pathways; they also serve as molecular markers in difficult diagnoses.
  • [MeSH-major] Chromosome Aberrations. Fibrosarcoma / pathology. Neoplasm Recurrence, Local / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Chromosome Banding. Disease Progression. Female. Humans. Karyotyping. Male. Middle Aged. Spectral Karyotyping

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16415793.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


82. He CY, Jin YL, Yang DM, Liu HG: [Clinicopathologic study of sinonasal inflammatory myofibroblastic tumor]. Zhonghua Bing Li Xue Za Zhi; 2010 Mar;39(3):166-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Actins / metabolism. Adult. Calcium-Binding Proteins / metabolism. Diagnosis, Differential. Female. Fibrosarcoma / pathology. Humans. Ki-67 Antigen / metabolism. Lymphatic Metastasis. Male. Microfilament Proteins / metabolism. Middle Aged. Neoplasm Recurrence, Local. Neurofibromatoses / pathology. Vimentin / metabolism

  • Genetic Alliance. consumer health - Inflammatory myofibroblastic tumor.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20450762.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / ACTA2 protein, human; 0 / Actins; 0 / Calcium-Binding Proteins; 0 / Ki-67 Antigen; 0 / Microfilament Proteins; 0 / Vimentin; 0 / calponin
  •  go-up   go-down


83. Takahama A Jr, León JE, de Almeida OP, Kowalski LP: Nonlymphoid mesenchymal tumors of the parotid gland. Oral Oncol; 2008 Oct;44(10):970-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Four malignant tumors were classified as rhabdomyosarcoma, fibrosarcoma, Langerhans cell histiocytosis and endodermal sinus tumor.
  • From the malignant cases, only the patient with fibrosarcoma died due the tumor, the other three are alive with no signs of recurrence.
  • All cases were treated by surgery with no recurrences, except one case of fibrosarcoma whose patient died of distant metastasis.
  • [MeSH-minor] Adolescent. Adult. Aged. Brazil. Child. Child, Preschool. Diagnosis, Differential. Endodermal Sinus Tumor / pathology. Female. Fibrosarcoma / pathology. Histiocytosis, Langerhans-Cell / pathology. Humans. Infant. Male. Middle Aged. Neurofibroma / pathology. Rhabdomyosarcoma / pathology. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18282791.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


84. Estep AL, Tidyman WE, Teitell MA, Cotter PD, Rauen KA: HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy. Am J Med Genet A; 2006 Jan 1;140(1):8-16
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To gain an understanding of the relationship between constitutional HRAS mutations and malignancy, HRAS was sequenced in an advanced biphasic rhabdomyosarcoma/fibrosarcoma from an individual with a 34G --> A mutation.
  • [MeSH-minor] Adolescent. Adult. Alleles. Base Sequence. Cardiovascular Abnormalities / pathology. Child. Child, Preschool. Codon / genetics. Cohort Studies. DNA Mutational Analysis. Face / abnormalities. Genetic Predisposition to Disease / genetics. Genotype. Humans. Infant. Intellectual Disability / pathology. Musculoskeletal Abnormalities / pathology. Neoplasms / genetics. Phenotype. Skin Abnormalities / pathology. Syndrome


85. Coelho PN, Banazol NG, Soares RJ, Fragata JI: Long-term survival with heart transplantation for fibrosarcoma of the heart. Ann Thorac Surg; 2010 Aug;90(2):635-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term survival with heart transplantation for fibrosarcoma of the heart.
  • Primary sarcoma of the heart is a rare disease that has an ominous prognosis with either medical or surgical therapy.
  • We report a case of a 25-year-old woman with sarcoma of the heart who received a transplant and is clinically well after 7 years.
  • [MeSH-major] Fibrosarcoma / surgery. Heart Neoplasms / surgery. Heart Transplantation
  • [MeSH-minor] Adult. Female. Humans. Survivors. Time Factors

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - Heart Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20667366.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


86. Zhang H, Wu D, Wang Z, Xu J, Wang H: Primary fibrosarcoma of the diaphragm with pleural effusion. Clin Respir J; 2010 Apr;4(2):127-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary fibrosarcoma of the diaphragm with pleural effusion.
  • [MeSH-major] Diaphragm / pathology. Fibrosarcoma / pathology. Fibrosarcoma / radiography. Pleural Effusion, Malignant / etiology. Thoracic Neoplasms / pathology. Thoracic Neoplasms / radiography
  • [MeSH-minor] Adult. Female. Humans. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20565488.001).
  • [ISSN] 1752-699X
  • [Journal-full-title] The clinical respiratory journal
  • [ISO-abbreviation] Clin Respir J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


87. Ayadi L, Charfi S, Khabir A, Kalle R, Sellami A, Makni S, Boudawara Z, Sellami-Boudawara T: [Cerebral gliosarcoma: clinico-pathologic study of 8 cases]. Tunis Med; 2010 Mar;88(3):142-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sarcomatous component had features of fibrosarcoma in 5 cases, osteosarcoma in 2 cases and malignant fibrous histiocytoma in 1 case.
  • [MeSH-minor] Adult. Aged. Female. Follow-Up Studies. Humans. Male. Middle Aged. Radiotherapy, Adjuvant. Retrospective Studies


88. Sharma H, Jane MJ, Reid R: Scapulo-humeral Paget's sarcoma: Scottish Bone Tumour Registry experience. Eur J Cancer Care (Engl); 2005 Sep;14(4):367-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Scapulo-humeral Paget's sarcoma: Scottish Bone Tumour Registry experience.
  • This study aimed to analyse the clinical, radiological and histological features of 16 scapulo-humeral Paget's sarcoma cases accrued from Scottish Bone Tumour Registry between January 1950 and December 2000.
  • Histology showed predominantly osteosarcoma (n = 12), followed by pleomorphic sarcoma (n = 2), malignant fibrous histiocytoma (n = 1) and fibrosarcoma (n = 1).
  • In summary, Paget's sarcoma of the scapulo-humeral area presents with progressively worsening pain, a painful mass with or without a pathological fracture, predominantly lytic in humeral and purely sclerotic in scapular lesions, osteosarcoma-dominant histology, primarily treated with an early limb ablative surgery and associated with a poor 1-year survival (12.5%) and 5-year survival (6.2%) rate.
  • [MeSH-minor] Adult. Aged. Female. Humans. Humeral Fractures / pathology. Humeral Fractures / radiography. Humeral Fractures / surgery. Male. Middle Aged. Pain / physiopathology. Registries. Scotland. Survival Analysis


89. Eyden B: The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure. part 2 - tumours and tumour-like lesions. J Submicrosc Cytol Pathol; 2005 Nov;37(3-4):231-96
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ultrastructural features are described of nodular fasciitis, the myofibromatoses (including Dupuytren's disease), inflammatory myofibroblastic tumour, post-operative spindle cell nodule, fibroma of tendon sheath, fibrous pseudotumour, benign fibrous histiocytoma, atypical fibroxanthoma, dermatofibrosarcoma protuberans, myofibrosarcoma (myofibroblastic sarcoma), malignant fibrous histiocytoma (pleomorphic myofibrosarcoma), epithelioid sarcoma and spindle-cell carcinoma.
  • Fibrosarcoma and leiomyosarcoma are illustrated for comparison.
  • [MeSH-minor] Adolescent. Adult. Animals. Female. Humans. Male. Microscopy, Electron, Transmission

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16612972.001).
  • [ISSN] 1122-9497
  • [Journal-full-title] Journal of submicroscopic cytology and pathology
  • [ISO-abbreviation] J. Submicrosc. Cytol. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 344
  •  go-up   go-down


90. Heletz I, Abramson SV: Large obstructive cardiac myxofibrosarcoma is nearly invisible on transthoracic echocardiogram. Echocardiography; 2009 Aug;26(7):847-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Malignant primary cardiac tumors are exceptionally rare, and the most common of these are sarcomas.
  • [MeSH-major] Echocardiography / methods. Fibrosarcoma / ultrasonography. Heart Atria / ultrasonography. Heart Neoplasms / ultrasonography
  • [MeSH-minor] Adult. Diagnostic Errors / prevention & control. False Negative Reactions. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19490014.001).
  • [ISSN] 1540-8175
  • [Journal-full-title] Echocardiography (Mount Kisco, N.Y.)
  • [ISO-abbreviation] Echocardiography
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


91. Berkmann S, Tolnay M, Hänggi D, Ghaffari A, Gratzl O: Sarcoma of the sella after radiotherapy for pituitary adenoma. Acta Neurochir (Wien); 2010 Oct;152(10):1725-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sarcoma of the sella after radiotherapy for pituitary adenoma.
  • We report the illustrative case of a 38-year-old man with acromegaly who had transsphenoidal surgery and radiotherapy 7 years before presenting with a sellar high-grade sarcoma.
  • We performed a thorough search of the literature and reviewed numerous publications and reports on primary and secondary sarcomas of the sella.
  • For further analysis, we identified and selected a group of patients based on the criteria for studying radiation-induced tumors as described by Cahan.Compared to the surgically treated group, secondary sarcomas of the sella are more frequent in patients who have had radiotherapy.
  • Radiation-induced sarcoma is a rare sequela of pituitary radiotherapy.
  • It is important for the treating physician to keep in mind the possibility of post-radiation sarcoma development.
  • [MeSH-major] Adenoma / radiotherapy. Fibrosarcoma / etiology. Fibrosarcoma / pathology. Pituitary Neoplasms / radiotherapy. Radiotherapy / adverse effects. Skull Base Neoplasms / etiology. Skull Base Neoplasms / pathology
  • [MeSH-minor] Adult. Humans. Male. Spinal Cord Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • MedlinePlus Health Information. consumer health - Radiation Therapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20512596.001).
  • [ISSN] 0942-0940
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Austria
  •  go-up   go-down


92. Pawlicki J, Król R, Kajor M, Ziaja J: [Case of malignant tumour phyllodes converting to fibrosarcoma]. Pol Merkur Lekarski; 2007 Mar;22(129):215-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Case of malignant tumour phyllodes converting to fibrosarcoma].
  • After surgical treatment of recurrent tumours (fibrosarcoma form) occurred two times during 1 year time.
  • [MeSH-major] Breast Neoplasms / pathology. Cell Transformation, Neoplastic / pathology. Fibrosarcoma / pathology. Neoplasm Recurrence, Local / pathology. Phyllodes Tumor / pathology
  • [MeSH-minor] Adult. Female. Follow-Up Studies. Humans. Mastectomy. Reoperation. Treatment Outcome

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17682679.001).
  • [ISSN] 1426-9686
  • [Journal-full-title] Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
  • [ISO-abbreviation] Pol. Merkur. Lekarski
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


93. Tsuchido K, Yamada M, Satou T, Otsuki Y, Shimizu S, Kobayashi H: Cytology of sclerosing epithelioid fibrosarcoma in pleural effusion. Diagn Cytopathol; 2010 Oct;38(10):748-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytology of sclerosing epithelioid fibrosarcoma in pleural effusion.
  • We report a case of sclerosing epithelioid fibrosarcoma focusing on its cytological features in pleural effusion.
  • The histological diagnosis was sclerosing epithelioid fibrosarcoma with a negative surgical margin.
  • A histological examination revealed a metastasis of sclerosing epithelioid fibrosarcoma, and chemotherapy was initiated.
  • The above cytological features, coupled with the clinical findings, enabled a diagnosis of sclerosing epithelioid fibrosarcoma.
  • To our knowledge, this is the first cytological description of sclerosing epithelioid fibrosarcoma.
  • [MeSH-major] Cytodiagnosis. Fibrosarcoma / secondary. Pleural Effusion, Malignant / pathology
  • [MeSH-minor] Adult. Buttocks / pathology. Epithelioid Cells / pathology. Humans. Immunohistochemistry. Lung Neoplasms / secondary. Male. Sclerosis / pathology. Soft Tissue Neoplasms / secondary

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 Wiley-Liss, Inc.
  • (PMID = 20091700.001).
  • [ISSN] 1097-0339
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. MacDonald MJ, Longacre MJ, Langberg EC, Tibell A, Kendrick MA, Fukao T, Ostenson CG: Decreased levels of metabolic enzymes in pancreatic islets of patients with type 2 diabetes. Diabetologia; 2009 Jun;52(6):1087-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In diabetic islets, the mRNA signal of the islet cell-enriched transcription factor musculoaponeurotic fibrosarcoma oncogene homologue A, which regulates expression of islet genes, including the PC gene, was decreased to 54% of the control level.

  • Genetic Alliance. consumer health - Diabetes.
  • Genetic Alliance. consumer health - Diabetes, Type 2.
  • MedlinePlus Health Information. consumer health - Diabetes Type 2.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Histochem Cytochem. 1975 Sep;23(9):660-5 [240882.001]
  • [Cites] Diabetes. 1991 Feb;40(2):227-32 [1825072.001]
  • [Cites] Diabetologia. 1993 Aug;36(8):722-6 [8405739.001]
  • [Cites] Diabetologia. 1994 Feb;37(2):177-81 [8163052.001]
  • [Cites] J Biol Chem. 2007 Oct 19;282(42):30596-606 [17724028.001]
  • [Cites] Diabetes. 1996 Nov;45(11):1626-30 [8866570.001]
  • [Cites] J Biol Chem. 2005 Mar 25;280(12):11107-13 [15664999.001]
  • [Cites] Diabetes. 2006 Feb;55(2):435-40 [16443778.001]
  • [Cites] Diabetologia. 2007 Feb;50(2):348-58 [17149590.001]
  • [Cites] Diabetes. 1996 Jul;45(7):886-90 [8666138.001]
  • (PMID = 19296078.001).
  • [ISSN] 1432-0428
  • [Journal-full-title] Diabetologia
  • [ISO-abbreviation] Diabetologia
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / DK028348-25; United States / NIDDK NIH HHS / DK / R01 DK028348-24; United States / NIDDK NIH HHS / DK / DK28348; United States / NIDDK NIH HHS / DK / DK028348-17; United States / NIDDK NIH HHS / DK / DK028348-18; United States / NIDDK NIH HHS / DK / DK028348-22; United States / NIDDK NIH HHS / DK / R01 DK028348-18; United States / NIDDK NIH HHS / DK / R01 DK028348-25; United States / NIDDK NIH HHS / DK / DK028348-23; United States / NIDDK NIH HHS / DK / R01 DK028348-17; United States / NIDDK NIH HHS / DK / R01 DK028348-20; United States / NIDDK NIH HHS / DK / DK028348-24; United States / NIDDK NIH HHS / DK / DK028348-16; United States / NIDDK NIH HHS / DK / R01 DK028348-16; United States / NIDDK NIH HHS / DK / R01 DK028348-21; United States / NIDDK NIH HHS / DK / R01 DK028348-19; United States / NIDDK NIH HHS / DK / R01 DK028348-27; United States / NIDDK NIH HHS / DK / DK028348-26; United States / NIDDK NIH HHS / DK / R01 DK028348-23; United States / NIDDK NIH HHS / DK / DK028348-20; United States / NIDDK NIH HHS / DK / R01 DK028348-22; United States / NIDDK NIH HHS / DK / R01 DK028348-26; United States / NIDDK NIH HHS / DK / R01 DK028348; United States / NIDDK NIH HHS / DK / DK028348-19; United States / NIDDK NIH HHS / DK / DK028348-21
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] EC 1.1.- / Glycerolphosphate Dehydrogenase; EC 1.1.1.37 / Malate Dehydrogenase; EC 1.1.1.41 / Isocitrate Dehydrogenase; EC 1.1.1.42 / isocitrate dehydrogenase (NADP+); EC 2.3.3.8 / ATP Citrate (pro-S)-Lyase; EC 2.6.1.1 / Aspartate Aminotransferases; EC 2.8.3.- / Coenzyme A-Transferases; EC 2.8.3.5 / 3-ketoacid CoA-transferase; EC 4.1.1.41 / Methylmalonyl-CoA Decarboxylase; EC 6.4.1.1 / Pyruvate Carboxylase
  • [Other-IDs] NLM/ NIHMS203397; NLM/ PMC2903059
  •  go-up   go-down


95. Huang HY, Li CF, Fang FM, Tsai JW, Li SH, Lee YT, Wei HM: Prognostic implication of ezrin overexpression in myxofibrosarcomas. Ann Surg Oncol; 2010 Dec;17(12):3212-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It is implicated in tumor progression and metastatic dissemination, and it is associated with adverse outcomes in several cancer types, including pediatric sarcomas.
  • [MeSH-major] Cytoskeletal Proteins / metabolism. Fibrosarcoma / metabolism. Myxosarcoma / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Blotting, Western. Cells, Cultured. Female. Fibroblasts / cytology. Fibroblasts / metabolism. Follow-Up Studies. Humans. Immunoenzyme Techniques. Male. Middle Aged. Neoplasm Staging. Prognosis. RNA, Messenger / genetics. Reverse Transcriptase Polymerase Chain Reaction. Survival Rate. Young Adult

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20585869.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cytoskeletal Proteins; 0 / RNA, Messenger; 0 / ezrin
  •  go-up   go-down


96. Guo H, Xiong Y, Nong L, Zhang S, Li T: [Reassessment of the pathological diagnosis in 33 cases of malignant fibrous histiocytoma]. Beijing Da Xue Xue Bao; 2008 Aug 18;40(4):374-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Since malignant fibrous histiocytoma (MFH) may be taken as an undifferentiated pleomorphic sarcoma (UPS), this study was conducted to reassess 33 previously diagnosed MFH cases in the past 10 years based on the latest WHO concept.
  • RESULTS: Among the 33 cases, 17 cases (51.5%) of MFH had their diagnoses changed, including 5 leiomyosarcomas, 3 malignant peripheral nerve sheath tumors, 1 fibrosarcoma, 1 inflammatory myofibrosarcoma, 1 giant cell tumor and 1 angiomatoid fibrous histiocytoma.
  • CONCLUSION: MFH/UPS often show marked histological pleomorphism, and the diagnosis must be made by exclusion of other definitive sarcomas, especially myogenic and neurogenic sarcoma.
  • In addition, histiocytic phenotypic marker did have more expression in MFH/UPS than in other sarcomas.
  • [MeSH-minor] Adult. Aged. Diagnosis, Differential. Humans. Immunohistochemistry. Middle Aged

  • Genetic Alliance. consumer health - Malignant fibrous histiocytoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18677383.001).
  • [ISSN] 1671-167X
  • [Journal-full-title] Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
  • [ISO-abbreviation] Beijing Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


97. Willems SM, Mohseny AB, Balog C, Sewrajsing R, Briaire-de Bruijn IH, Knijnenburg J, Cleton-Jansen AM, Sciot R, Fletcher CD, Deelder AM, Szuhai K, Hensbergen PJ, Hogendoorn PC: Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix. J Cell Mol Med; 2009 Jul;13(7):1291-301
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Extracellular Matrix / metabolism. Fibrosarcoma / genetics. Myxoma / genetics
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Chromatography, Liquid. DNA Mutational Analysis. Extracellular Matrix Proteins / metabolism. Female. GTP-Binding Protein alpha Subunits, Gs / genetics. Gene Expression Regulation, Neoplastic. Humans. Immunohistochemistry. Karyotyping. Male. Mass Spectrometry. Middle Aged. Polymerase Chain Reaction. Proto-Oncogene Proteins / genetics. RNA, Messenger / genetics. RNA, Messenger / metabolism. Tumor Suppressor Protein p53 / genetics. ras Proteins / genetics

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19320777.001).
  • [ISSN] 1582-4934
  • [Journal-full-title] Journal of cellular and molecular medicine
  • [ISO-abbreviation] J. Cell. Mol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Extracellular Matrix Proteins; 0 / KRAS protein, human; 0 / Proto-Oncogene Proteins; 0 / RNA, Messenger; 0 / Tumor Suppressor Protein p53; EC 3.6.1.- / GNAS protein, human; EC 3.6.5.1 / GTP-Binding Protein alpha Subunits, Gs; EC 3.6.5.2 / ras Proteins
  • [Other-IDs] NLM/ PMC4496143
  •  go-up   go-down


98. Wang M, Khurana RN, Parikh JG, Hidayat AA, Rao NA: Myxofibrosarcoma of the orbit: an underrecognized entity? Case report and review of the literature. Ophthalmology; 2008 Jul;115(7):1237-1240.e2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSIONS: For historical reasons, MFS involving the orbit is likely to be underrecognized and categorized erroneously as malignant fibrous histiocytoma or other soft tissue sarcoma.
  • Although orbital MFS is an extremely rare diagnosis, ophthalmologists should be aware of the possibility and consider a diagnosis of MFS when an adult seeks treatment for an orbital tumor with aggressive growth.
  • [MeSH-major] Fibrosarcoma / pathology. Orbital Neoplasms / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18096231.001).
  • [ISSN] 1549-4713
  • [Journal-full-title] Ophthalmology
  • [ISO-abbreviation] Ophthalmology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


99. Perez EA, Gutierrez JC, Moffat FL Jr, Franceschi D, Livingstone AS, Spector SA, Levi JU, Sleeman D, Koniaris LG: Retroperitoneal and truncal sarcomas: prognosis depends upon type not location. Ann Surg Oncol; 2007 Mar;14(3):1114-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retroperitoneal and truncal sarcomas: prognosis depends upon type not location.
  • BACKGROUND: Prognostication of truncal and retroperitoneal soft tissue sarcomas has traditionally been predicated on tumor location and grade.
  • OBJECTIVE: To compare outcomes for patients with retroperitoneal or truncal sarcomas.
  • Liposarcoma and fibrosarcoma were associated with improved survival (P < 0.0001).
  • CONCLUSIONS: Successful operative resection can confer prolonged disease-free survival and cure for truncal and retroperitoneal sarcomas.
  • Future studies should focus on histological subtype rather than tumor location for truncal and retroperitoneal sarcomas.
  • [MeSH-major] Retroperitoneal Neoplasms / pathology. Sarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Extremities / pathology. Female. Fibrosarcoma / drug therapy. Fibrosarcoma / pathology. Fibrosarcoma / surgery. Histiocytoma, Benign Fibrous / drug therapy. Histiocytoma, Benign Fibrous / pathology. Histiocytoma, Benign Fibrous / surgery. Humans. Leiomyosarcoma / drug therapy. Leiomyosarcoma / pathology. Leiomyosarcoma / surgery. Liposarcoma / drug therapy. Liposarcoma / pathology. Liposarcoma / surgery. Male. Middle Aged. Prognosis. Retrospective Studies. Risk Factors. Survival Rate. Time Factors

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17206483.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


100. Kordek R, Sowa P, Panasiuk M, Kmieciak M, Chudobinski C, Pluciennik E, Bednarek AK, Potemski P, Jesionek-Kupnicka D: Primary osseous rhabdomyosarcoma with focal matrix formation mimicking osteosarcoma. Pathol Res Pract; 2007;203(12):873-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Other bone tumors with rhabdomyosarcomatous differentiation have been described: dedifferentiated chondrosarcoma, fibrosarcoma, and osteosarcoma.
  • [MeSH-minor] Actins / analysis. Adult. Biomarkers, Tumor / analysis. Desmin / analysis. Diagnosis, Differential. Humans. Magnetic Resonance Imaging. Male. MyoD Protein / analysis. Myogenin / analysis

  • Genetic Alliance. consumer health - Osteosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17905523.001).
  • [ISSN] 0344-0338
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Actins; 0 / Biomarkers, Tumor; 0 / Desmin; 0 / MYOG protein, human; 0 / MyoD Protein; 0 / MyoD1 myogenic differentiation protein; 0 / Myogenin
  •  go-up   go-down






Advertisement